腎生検病理アトラス　改訂版

出版社： 東京医学社
著者：
発行日： 2017-08-15
分野： 臨床医学：内科  >  腎臓
ISBN： 9784885632860
電子書籍版： 2017-08-15 （第2版第1刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

11,000 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

11,000 円(税込)

購入する

商品紹介

今回の改訂は、新しい疾患概念に対応し、かつ最新の臨床病理学的な情報を盛り込むことで、さらに腎疾患の病理を病因から理解できるように編集しました。

目次

  • 腎生検病理アトラス　改訂版

    ―目次―

    臨床情報
    　腎生検病理診断に必要な臨床情報
    　腎生検臨床情報記載用紙：成人
    　腎生検臨床情報記載用紙：小児
    　腎生検報告書の書き方と腎病理診断の標準化

    腎病理総論
    　腎生検に必要な各種染色法
    　所見の捉え方：光学顕微鏡
    　所見の捉え方：免疫抗体法
    　所見の捉え方：電子顕微鏡

    疾患分類
    　糸球体腎炎のWHO分類の変遷と今後の方向
    　尿細管・間質・血管病変の分類

    各論：糸球体病変
    　微小変化型ネフローゼ症候群
    　巣状分節性糸球体硬化症
    　膜性腎症
    　IgA腎症
    　紫斑病性腎炎（IgA血管炎）
    　抗GBM病
    　膜性増殖性糸球体腎炎
    　C3腎症：dense deposit病とC3腎炎
    　ループス腎炎と抗リン脂質抗体症候群
    　糖尿病性腎症
    　腎アミロイドーシス
    　細線維性腎炎とイムノタクトイド糸球体症
    　爪膝蓋骨症候群と膠原線維沈着性糸球体症
    　クリオグロブリン血症性糸球体腎炎
    　軽鎖沈着症，重鎖沈着症，軽鎖重鎖沈着症
    　単クローン性IgG沈着を伴う増殖性糸球体腎炎
    　フィブロネクチン腎症
    　リポプロテイン糸球体症
    　Alport症候群，菲薄基底膜病
    　先天性ネフローゼ症候群
    　Fabry病
    　ミトコンドリア異常症

    各論：感染関連腎炎
    　溶連菌感染後急性糸球体腎炎
    　細菌感染性腎炎
    　ウイルス関連糸球体腎炎
    　肝疾患に関連した腎病変

    各論：血管病変
    　腎硬化症
    　血管炎症候群
    　ANCA関連血管炎（AAV）
    　血栓性微小血管症
    　全身性硬化症（強皮症腎）
    　コレステロール塞栓症（アテローム塞栓症）

    各論：尿細管間質性病変
    　急性尿細管傷害／壊死
    　尿細管間質性腎炎
    　肉芽腫性間質性腎炎
    　腎盂腎炎
    　IgG4関連腎臓病
    　代謝性尿細管障害
    　ネフロン癆／常染色体優性尿細管間質性腎疾患（ADTKD）

    各論：移植腎病変
    　拒絶反応（バンフ分類）
    　移植腎の薬剤性障害
    　移植腎のウイルス性腎症
    　移植後リンパ増殖性疾患
    　腎移植後の再発腎炎，新生腎炎

    各論：随伴性腎疾患
    　骨髄移植と腎障害
    　妊娠高血圧腎症
    　薬剤性腎障害（分子標的薬）
    　Castleman病，POEMS症候群，TAFRO症候群（Castleman-Kojima病）

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

臨床情報

P.17 掲載の参考文献
1. 木村健二郎 (編・著). 腎疾患の概要. 腎生検から学ぶ腎臓病学. 2nd ed, 東京 : 診断と治療社, 2002, 2-4.
 
2. Grossfeld GD, et al. Evaluation of asymptomatic microscopic hematuria in adults : the American Urological Association best practice policy-part I : Definition, detection, prevalence, and etiology. Urology 2001 ; 57 : 599-603.
 
3. 堀江重郎, ほか : 顕微鏡的血尿の診断, 血尿診断ガイドライン 2013. 血尿診断ガイドライン編集委員会 (編). 東京 ; ライフサイエンス出版, 2013, 19-22.
 
4. 日本腎臓学会. 一般臨床医のための検尿の考え方・進め方. 第4章 臨床に役立つフローチャート蛋白尿・血尿 (1). 2003.
 
5. Steinhauslin F, Wauters JP. Quantitation of proteinuria in kidney transplant patients : accuracy of the urinary protein/creatinine ratio. Clin Nephrol 1995 ; 43 : 110-115.
PubMed
6. 日本腎臓学会, ほか. CKDの診断と意義, エビデンスに基づくCKDガイドライン 2013, 1-6, 東京 : 東京医学社, 2013.
 
7. Stevens LA, et al. Assessing kidney function-measured and estimated glomerular filtration rate. N Engl J Med 2006 ; 354 : 2473-2483.
PubMed
8. 原茂子, ほか. クリオグロブリン血症. 日内会誌 2005 ; 94 : 906-914.
 
9. Tojo A, et al. Silent lupus nephritis with fingerprint deposits. Intern Med 1993 ; 32 : 323-326.
PubMed
10. 日本腎臓学会, ほか. 糖尿病性腎症, エビデンスに基づくCKDガイドライン 2013. 1-611, 東京 : 東京医学社, 2013.
 
11. Parving HH, et al. Prevalence and causes of albuminuria in non-insulin-dependent diabetic patients. Kidney Int 1992 ; 41 : 758-762.
PubMed
P.22 掲載の参考文献
1. 御手洗哲也. 糸球体疾患の病理診断に必要な臨床情報. 病理と臨床 2001 ; 19 : 922-926.
Medical*Online
2. 西慎一. 生検前のチェック項目. 日本腎臓学会・腎生検検討委員会 (編), 腎生検ガイドブック. 東京 : 東京医学社, 2004.
 
3. 堀尾 勝 : 採尿しないCcr推算式 (その導き方と応用). 日本腎臓学会 (編集代表折田義正, 下条文武), 腎機能 (GFR) ・尿蛋白測定ガイドライン. 東京 : 東京医学社, 2003.
 
4. 6-1 腎機能の評価法 : 成人. 日本腎臓学会 (編), CKD診療ガイド 2012. 東京 : 東京医学社, 2012.
 
P.25 掲載の参考文献
1. Uemura O, et al. Age, gender, and body length effects on reference serum creatinine levels determined by an enzymatic method in Japanese children : a multicenter study. Clin Exp Nephrol 2011 ; 15 : 694-699.
PubMed
2. Uemura O, et al. Creatinine-based equation to estimate the glomerular filtration rate in Japanese children and adolescents with chronic kidney disease. Clin Exp Nephrol 2014 ; 18 : 626-633.
PubMed
3. Nagai T, et al. Creatinine-based equations to estimate glomerular filtration rate in Japanese children aged between 2 and 11 years old with chronic kidney disease. Clin Exp Nephrol 2013 ; 17 : 877-881.
PubMed
4. Yata N, et al. Reference ranges for serum cystatin C measurements in Japanese children by using 4 automated assays. Clin Exp Nephrol 2013 ; 17 : 872-876.
PubMed
5. Uemura O, et al. Cystatin C-based equation for estimating glomerular filtration rate in Japanese children and adolescents. Clin Exp Nephrol 2014 ; 18 : 718-725.
PubMed
P.30 掲載の参考文献
1. 城謙輔. 糸球体腎炎の病理診断-臨床に役立つ病理診断法の手引き-. 腎生検診断のスケルトン (光学顕微鏡・免疫・電子顕微鏡). 病理と臨床 2001 ; 19 : 927-936.
 
2. 城謙輔. 腎生検病理ABC臨床に役立つ病理診断法の手引き. 一次性糸球体疾患, 二次性糸球体腎炎の理解のための組織病型の基本とその鑑別について. 病理と臨床 2006 ; 24 : 1031-1042.
 
3. 種田積子, 本田一穂. 腎生検ガイドライン. 腎と透析 (増刊号) 2012 ; 72 : 174-181.
 
4. 城謙輔, 田口尚. 腎病理診断標準化への取り組み. 日腎会誌 2009 ; 51 : 506-514.
 
5. Sethi S, et al. Mayo Clinic/Renal Pathology Society Consensus Report on Pathologic Classification, Diagnosis, and Reporting of GN. J Am Soc Nephrol 2016 ; 27 : 1278-1287.
 

腎病理総論

P.41 掲載の参考文献
1. 病理技術マニュアル 3「病理組織標本作製技術」上巻 切り出しから薄切まで. 日本病理学会 (編). 医歯薬出版, 東京, 1981.
 
2. 病理技術マニュアル 3「病理組織標本作製技術」下巻染色法. 日本病理学会 (編). 東京 : 医歯薬出版, 1981.
 
3. 新染色法のすべて. 東京 : 医歯薬出版, 1999.
 
4. 城謙輔, ほか. 腎障害における脂質関与の形態的証明. Nephrol Frontier 2003 ; 2 : 34-44.
Medical*Online
P.52 掲載の参考文献
1. 城謙輔. 1. 腎臓の正常構造とその名称. ジョーシキ! 腎生検電顕ATLAS, 3-13, 東京 : 南山堂, 2016.
 
2. 坂井建雄, ほか. カラー図解 V. 腎・泌尿器, 人体の正常構造と機能. 1-33, 東京 : 日本医事新報社, 2017.
 
3. 城謙輔. 病理医のための組織学シリーズ-腎臓-. 病理と臨床 2004 ; 22 : 49 3-503.
 
4. Word Health Organization. Churg J, et al (eds). Renal Disease Class1- fication and Atlas of Glomerular Diseases. 2nd ed. Tokyo : IGAKU-SHOIN, 1995.
 
5. Kumar V, et al. Robbins & Cotran Pathologic Basis of Disease, 7th Ed, Philadelphia : W BS aunders, 2014.
 
6. Word Health Organization. Seshan S, et al (e ds). Renal Disease Classification and Atlas of Tubulointerstitial and Vascular Diseases. 2nd ed. New York : 羽TiliamWilkins, 1999.
 
7. 重松秀一, ほか (監訳). 腎疾患の病理アトラスー尿細管間質疾患と血管疾患のWHO分類. 東京 : 東京医学社, 2005.
 
8. Wilhelmus S, et al. The Revisited Classification of GN in SLE at 10 Years : Time to Re-Evaluate Histopathologic Lesions. Am Soc Nephrol 2015 ; 26 : 2938-2946.
PubMed
9. 城謙輔. ループス腎炎病理組織分類改訂より10年後の評価. 腎と透析 2016 ; 81 : 383-393.
Medical*Online
10. Cattran D, et al. A Working Group of the International IgA Nephropathy Network and the Renal Pathology Society. The Oxford classification of IgA nephropathy . rationale, clinicopathological correlations, and classification. Kidney Int 2009 ; 76 : 534-545.
 
11. Roberts I, et al. A Working Group of the International IgA Nephropathy Network and the Renal Pathology Society. The Oxford classification of IgA nephropathy : pathology definitions, correlations, and reproducibility. Kidney Int 2009 ; 76 : 546-556.
 
P.61 掲載の参考文献
1. Sethi S, et al. Mayo Clinic/Renal Pathology Society consensus report on pathologic classification, diagnosis, and reporting of GN. J Am Soc Nephrol 2016 ; 27 : 1278-1287.
 
2. 小川弥生, ほか. 糸球体腎炎. 病理と臨床 臨時増刊号 2014 ; 32 : 327-332.
 
3. Nasr SH, et al. Immunofluorescence on pronase-digested paraffin sections : A valuable salvage technique for renal biopsies. Kidney Int 2006 ; 70 : 2148-2151.
PubMed
4. Huang CG, et al. IgG subclass staining in renal biopsies with membranous glomerulonephritis indicates subclass switch during disease progression. Mod Pathol 2013 ; 26 : 799-805.
 
5. Hemminger J, et al. IgG subclass staining in routine renal biopsy material. Am J Surg Pathol 2016 ; 40 : 617-626.
PubMed
P.74 掲載の参考文献
1. Bonsib SM. Renal anatomy and Histology. Jennette JC, et al. Heptinstall's Pathology of the Kidney, Seventh Edition. 1-66, Philadelphia : Wolters Kluwer, 2015.
 
2. Tryggvason K, Patrakka J. Thin basement membrane nephropathy. J Am Soc Nephlology 2006 ; 17 : 813-822.
PubMed
3. 城謙輔, 浜口欣一. 腎生検病理診断総論電顕診断. 腎と透析 2003 ; 54 : 390-398.
 
4. Bonsib SM. Renal anatomy and Histology. Jennette JC, et al. Heptinstall's Pathology of the Kidney, Seventh Edition. 1015-1037, Philadelphia : Wolters Kluwer, 2015.
 

疾患分類

P.80 掲載の参考文献
1. Churg J, et al. Renal Disease. Classification and Atlas of Glomerular Diseases. Churg J , et al (eds). Second edition, Tokyo New York : Igakushoin, 1995.
 
2. Jennette JC, et al. 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 2013 ; 65 : 1-11.
 
3. Joh K, et al. Renal pathology of ANCA-related vasculritis : proposal for standardization of pathological diagnosis in Japan. Clin Exp Nephrol 2008 : 12 : 277-291.
PubMed
4. 重松秀一. 急速進行性腎炎症候群の組織障害とその進展. 腎臓は身体の鏡. 203-213, 長野 : 信教印刷, 2004.
 
5. Sanjeev S, et al. Mayo Clinic/Renal Pathology Society Conference Report on Pathologic Classification, Diagnosis, and Reporting of GN. J Am Soc Nephrol 2016 ; 27 : 1278-1287.
 
6. Weening JJ, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int 2004 ; 65 : 521-530.
PubMed
7. 川村哲也, ほか. IgA腎症の新たな重症度分類の試案. 御手洗哲也, ほか (編). Annual Review 腎臓 2009, 87-94, 東京 : 中外医学社. 2009.
 
8. Berden AE, et al. Histopathologic classification of ANCA-associated glomerulonephritis. J Am Soc Nephrol 2010 ; 21 : 1628-1636.
PubMed
P.88 掲載の参考文献
1. Colvin RB. Classification of tubulointerstitial diseases. In : Diagnostic pathology. Kidney diseases. 1st edition, 4-2-4-3, Philadelphia : Lippincott Williams & Wilkins. 2011.
 
2. Eckardt KU, et al. Autosomal dominant tubulointerstitial kidney disease : diagnosis, classification, and management-A KDIGO consensus report. Kidney Int 2015 ; 88 : 676-683.
PubMed
3. Ito S, et al. Thyroidization in renal allografts. Clin Transplant 2009 ; 23 (Suppl 20) : 6-9.
 
4. Imasawa T, et al. Pathological similarities between low birth weightrelated nephropathy and nephropathy associated with mitochondrial cytopathy. Diagn Pathol 2014 ; 9 : 181.
PubMed
5. Yamaguchi Y, et al. Characteristic tubulointerstitial nephritis in IgG4-related disease. Hum Pathol 2012 ; 43 : 536-549.
PubMed
6. Jennette JC, et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 2013 ; 65 : 1-11.
 

各論 : 糸球体病変

P.96 掲載の参考文献
1. Vivarelli M, et al. Minimal Change Disease. Clin J Am Soc Nephrol 2016 : 12 : 332-345.
PubMed
2. Saha TC, et al. Minimal change disease : a review. South Med J 2006 ; 99 : 1264-1270.
PubMed
3. Glassock RJ. Secondary minimal change disease. Nephrol Dial Transplant 2003 ; 18 (Suppl 6) : vi52-58.
 
4. Dijkman HB, et al. Glomerular involution in children with frequently relapsing minimal change nephrotic syndrome : an unrecognized form of glomerulosclerosis? Kidney Int 2007 ; 71 : 44-52.
PubMed
5. Howie AJ. Pathology of minimal change nephropathy and segmental sclerosing glomerular disorders. Nephrol Dial Transplant 2003 ; 18 (Suppl 6) : vi33-8.
 
6. Myllymaki J, et al. IgM nephropathy : clinical picture and long-term prognosis. Am J Kidney Dis 2003 ; 41 : 343-350.
PubMed
7. Cohen AH, et al. Nephrotic syndrome with glomerular mesangial IgM deposits. Lab Invest 1978 ; 38 : 610-619.
PubMed
8. Bhasin HK, et al. Mesangial proliferative glomerulonephritis. Lab Invest 1978 ; 39 : 21-29.
PubMed
9. Connor TM, et al. The natural history of immunoglobulin M nephropathy in adults. Nephrol Dial Transplant 2016 ; pii : gfw063 [Epub ahead of print].
 
10. Jennette JC, et al. C1q nephropathy : a distinct pathologic entity usually causing nephrotic syndrome. Am J Kidney Dis 1985 ; 6 : 103-110.
PubMed
11. Vizjak A, et al. Pathology, clinical presentations, and outcomes of C1q nephropathy. J Am Soc Nephrol 2008 ; 19 : 2237-2244.
 
P.104 掲載の参考文献
1. Rich AR. A hitherto undescribed vulnerability of the juxta-medullary glomeruli in lipolipoid nephrosis. Bull Johns Hopkins Hosp 1957 ; 100 : 173-186.
 
2. Churg J, et al. Pathology of the nephrotic syndrome in children : a report for the International Study of Kidney Disease in Children. Lancet 1970 ; 760 : 1299-1302.
 
3. Churg J, et al. Classification of glomerular disease. In Renal Disease. 2nd edition, New York, Tokyo : Igakushoin, 1995 : 45-57.
 
4. D'Agati VD. Podocyte injury in focal segmental glomerulosclerosis : Lessons from animal models (a play in five acts). Kidney Int 2008 ; 73 : 399-406.
PubMed
5. Cattran DC, et al. Cyclosporin in idiopathic glomerular disease associated with the nephrotic syndrome : workshop recommendations. Kidney Int 2007 ; 72 : 1429-1447.
PubMed
6. Schwartz MM. Focal segmental glomerulosclerosis, in Heptinstall's Pathology of the Kidney. Philadelphia : Lippincott Williams & Wilkins, 2005 : 156-204.
 
7. D'Agati VD, et al. Pathologic classification of focal segmental glomerulosclerosis : a working proposal. Am J Kid Dis 2004 ; 43 : 368-382.
PubMed
8. Deegens JK, et al. Podocyte foot process effacement as a diagnostic tool in focal segmental glomerulosclerosis. Kidney Int 2008 ; 74 : 1568-1576.
PubMed
P.112 掲載の参考文献
1. Beck LH Jr, et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 2009 ; 361 : 11-21.
PubMed
2. Tomas NM, et al. Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy. N Engl J Med 2014 ; 371 : 2277-2287.
PubMed
3. Debiec H, et al. Antenatal membranous glomerulonephritis due to anti-neutral endopeptidase antibodies. N Engl J Med 2002 ; 346 : 2053-2060.
PubMed
4. Hoxha E, et al. An Indirect Immunofluorescence Method Facilitates Detection of Thrombospondin Type 1 Domain-Containing 7A-Specific Antibodies in Membranous Nephropathy. J Am Soc Nephrol 2017 ; 28 : 520-531.
PubMed
5. Imai H, et al. IgG subclasses in patients with membranoproliferative glomerulonephritis, membranous nephropathy, and lupus nephritis. Kidney Int 1997 ; 51 : 270-276.
PubMed
6. Hirayama K, et al. Predominance of type-2 immune response in idiopathic membranous nephropathy. Cytoplasmic cytokine analysis. Nephron 2002 ; 91 : 255-261.
PubMed
7. Kuroki A, et al. Th2 cytokines increase and stimulate B cells to produce IgG4 in idiopathic membranous nephropathy. Kidney Int 2005 ; 68 : 302-310.
PubMed
8. Shiiki H, et al. Research Group on Progressive Renal Diseases in Japan : Prognosis and risk factors for idiopathic membranous nephropathy with nephrotic syndrome in Japan. Kidney Int 2004 ; 65 : 1400-1407.
 
9. Wakai S, et al. Focal glomerulosclerosis in idiopathic membranous glomerulonephritis. Kidney Int 1992 ; 41 : 428-434.
PubMed
10. Kurihara I, et al. Clinicopathological characteristics of interstitial foam cells in membranous nephropathy. Kidney Int (Suppl) 1999 ; 71 : S144-146.
PubMed
11. Hemminger J, et al. IgG Subclass Staining in Routine Renal Biopsy Material. Am J Surg Pathol 2016 ; 40 : 617-626.
PubMed
12. Ehrenreich T, et al. Pathology of membranous nephropathy. In the Pathology Annual No.3, Sommers SC (ed), 145-186, New York : Appleton-Century-Crofts, 1968.
 
13. Nasr SH, et al. Membranous glomerulonephritis with ANCA-associated necrotizing and crescentic glomerulonephritis. Clin J Am Soc Nephrol 2009 ; 4 : 299-308.
PubMed
14. Honda K, et al. De novo membranous nephropathy and antibodymediated rejection in transplanted kidney. Clin Transplant 2011 ; 25 : 191-200.
PubMed
15, Hoxha E, et al. An Indirect Immunofluorescence Method Facilitates Detection of Thrombospondin Type 1 Domain-Containing 7A-Specific Antibodies in Membranous Nephropathy. J Am Soc Nephrol 2017 ; 28 : 520-531.
PubMed
16. Alexander MP, et al. Membranous glomerulonephritis is a manifestation of IgG4-related disease. Kidney Int 2013 ; 83 : 455-462.
PubMed
P.118 掲載の参考文献
1. 城謙輔. 23. 腎 2 IgA腎症病理. 最新医学別冊新しい診断と治療のABC. 東京 : 最新医学社, 26-32, 2004.
 
2. 厚生労働科学研究費補助金難治性疾患克服研究事業進行性腎障害に関する調査研究班報告IgA腎症分科会. IgA腎症診療指針-第3版-. 日腎会誌 2011 ; 53 : 123-135.
 
3. 厚生労働省特定疾患進行性腎障害研究班, IgA腎症分科会, 社団法人日本腎臓学会合同委員会. エビデンスに基づくIgA腎症診療ガイドライン. 1-124, 2014.
 
4. Ibels LS, et al. IgA nephropathy : Analysis of the natural history, important factors in the progression of renal disease, and a review of the literature. Medicine 1994 ; 73 : 79-102.
 
5. D'Amigo G. Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome. Semin Nephrol 2004 ; 24 : 179-196.
 
6. Haas M, et al. A Multicenter Study of the Predictive Value of Crescents in IgA Nephropathy. J Am Soc Nephrol 2016 Sep 9. pii : ASN.2016040433. [Epub ahead of print]
 
7. Katafuchi R, et al. Validation study of oxford classification of IgA nephropathy : the significance of extracapillary proliferation. Clin J Am Soc Nephrol 2011 ; 6 : 2806-2813.
PubMed
8. Roberts I, et al. A Working Group of the International IgA Nephropathy Network and the Renal Pathology Society. The Oxford classification of IgA nephropathy : pathology definitions, correlations, and reproducibility. Kidney Int 2009 ; 76 : 546-556.
 
9. Kurosu A, et al. Infantile immunoglobulin A nephropathy showing features of membranoproliferative glomerulonephritis. Tohoku J Exp Med 2012 ; 228 : 253-258.
PubMed
10. 城謙輔. IgA腎症. 腎生検電子顕微鏡アトラス, 124-130, 東京 : 南山堂, 2016.
 
11. Nasr SH, et al. IgA-dominant postinfectious glomerulonephritis : a new twist on an old disease. Nephron Clin Pract 2011 ; 119 : c18-25.
 
12. Kawamura T, et al. A histologic classification of IgA nephropathy for predicting long-term prognosis : emphasis on end-stage renal disease. J Nephrol 26 : 350-357, 2013.
PubMed
13. Cattran D, et al (. A Working Group of the International IgA Nephropathy Network and the Renal Pathology Society). The Oxford classification of IgA nephropathy : rationale, clinicopathological correlations, and classification. Kidney Int 2009 ; 76 : 534-542.
 
14. 川村哲也, ほか. IgA腎症の新たな重症度分類の試案. 御手洗哲也, ほか (編). Annual Review 腎臓 2009. 87-94, 東京 : 中外医学社, 2009.
 
15. 城謙輔. IgA腎症国際組織分類 (オックスフォード分類) の問題点. 御手洗哲也, ほか (編). Annual Review 腎臓 2010. 90-98,東京 : 中外医学社, 2010.
 
16. Joh K, et al. Differences of Histological Classification Between the Japanese Histological Grade Classification and the Oxford Classification, Tomino Y (ed.), Pathogenesis and Treatment in IgA Nephropathy. 69-88, Tokyo : Splinger Japan, 2016.
 
P.125 掲載の参考文献
1. Heberden WW. Comementarii di morborium historia et curatione. Paye, 1801. Reprinted as Commentaries on the History and Cure of Disease. Birmingham : The Classics of Medicine Library, 395-397, London : Division of Gryphon Editions, 1982.
 
2. Schonlein JL. Allgemeine und Speicielle Pathologie und Therapie. Wurzburg : Etlinger, 1832.
 
3. Henoch EH. Uber eine eigenthumliche form von purpura. Berl Klin Wochenschr 1874 ; 11 : 641-643.
 
4. Osler W. The visceral lesions of purpura and allied conditions. Br Med J 1914 ; 1 : 517-525.
PubMed
5. Jennette JC, et al. 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 2013 ; 65 : 1-11.
 
6. 遠藤正之. 紫斑病性腎炎. 内山聖, ほか (編). 専門医のための腎臓病学. 421-428,東京 : 医学書院, 2009.
 
7. 金子一成. 紫斑病性腎炎-小児科の視点. 専門医のための腎臓病学. 内山聖, 富野康日己, 今井裕一 (編). 東京 : 医学書院, 2009 : 428-432.
 
8. Haas M. IgA Nephropathy and IgA Vasculitis (Henoch- Schonlein Purpura) Nephritis. Jennette JC, et al (eds). In Heptinstall's Pathology of The Kidney, ed 7th, 463-523, Philadelphia : Wolters Kluwer, 2015.
 
9. Davin JC, et al. What is the difference between IgA nephropathy and Henoch- Schonlein purpura nephritis. Kidney Int 2001 ; 59 : 823-834.
PubMed
10. Davin JC, et al. Henoch-Schonlein nephritis in children. Nat Rev Nephrol 2014 ; 10 : 563-573.
PubMed
11. Novak J, et al. New insights into the pathogenesis of IgA nephropathy. Kidney Dis 2015 ; 1 : 8-18.
PubMed
12. Mestecky J, et al. IgA nephropathy enigma. Clinic Immunol 2016 ; 172 : 72-77.
 
13. Appel GB, et al. Schonlein-Henoch Purpura. Brenner BM (ed), In Brenner & Rector's The Kidney, ed 17th, 1411-1415, Philadelphia : Sanders, 2004.
 
14. Tomana M, et al. Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies. J Clin Invast 1999 ; 104 : 73-81.
 
15. Suzuki H, et al. Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity. J Clin Invast 2009 ; 119 : 1668-1677.
 
16. Endo M, et al. Complement activation through the lectin pathway with Henoch-Schonlein purpura nephritis. Am J Kidney Dis 2000 ; 35 : 401-407.
PubMed
17. Hisano S, et al. Activation of the lectin complement pathway in Henoch-Schonlein purpura nephritis. Am J Kidney Dis 2005 ; 45 : 295-302.
PubMed
P.130 掲載の参考文献
1. Hirayama K, et al. Anti-glomerular basement membrane antibody disease in Japan : part of the nationwide rapidly progressive glomerulonephritis survey in Japan. Clin Exp Nephrol 2008 ; 12 : 339-347.
PubMed
2. Jennette JC, et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 2013 ; 65 : 1-11.
 
3. Pedchenko V, et al. Molecular architecture of the Goodpasture autoantigen in anti-GBM nephritis. N Engl J Med 2010 ; 363 : 343-354.
PubMed
4. Cui Z, et al. Advances in human antiglomerular basement membrane disease. Nat Rev Nephrol 2011 ; 7 : 697-705.
PubMed
5. Zhao J, et al. The immunoglobulin G subclass distribution of anti-GBM autoantibodies against rHalpha3 (IV) NC1 is associated with disease severity. Hum Immunol 2009 ; 70 : 425-429.
PubMed
6. 急速進行性糸球体腎炎診療指針作成合同委員会. 急速進行性腎炎症候群の診療指針 第2版. 日腎会誌 2011 ; 53 : 509-555.
 
7. 厚生労働省難治性疾患克服研究事業進行性腎障害に関する調査研究班. エビデンスに基づく急速進行性腎炎症候群 (RPGN) 診療ガイドライン 2014. 日本腎臓学会, 東京 : 東京医学社, 2014.
 
8. Hellmark T, et al. Diagnosis and classification of Goodpasture's disease (anti-GBM). J Autoimmun 2014 ; 48-49 : 108-112.
 
9. Nasr SH, et al. The clinicopathologic characteristics and outcome of atypical anti-glomerular basement membrane nephritis. Kidney Int 2016 ; 89 : 897-908.
PubMed
10. Rutgers A, et al. Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis. Am J Kidney Dis 2005 ; 46 : 253-262.
PubMed
11. Jia XY, et al. The clinical and immunological features of patients with combined anti-glomerular basement membrane disease and membranous nephropathy. Kidney Int 2014 ; 85 : 945-952.
PubMed
12. Hudson BG, et al. Alport's syndrome, Goodpasture's syndrome, and type IV collagen. N Engl J Med 2003 ; 348 : 2543-2556.
PubMed
13. Ho J, et al. Antigenic heterogeneity of IgA anti-GBM disease : new renal targets of IgA autoantibodies. Am J Kidney Dis 2008 ; 52 : 761-765.
PubMed
P.138 掲載の参考文献
1. Sethi S, et al. Membranoproliferative glomerulonephritis--a new look at an old entity. N Engl J Med 2012 ; 366 : 1119-1131.
 
2. Barbour TD, et al. Recent insights into C3 glomerulopathy. Nephrol Dial Transplant 2013 ; 28 : 1685-1693.
PubMed
3. Nasr SH, et al. Proliferative glomerulonephritis with monoclonal IgG deposits. J Am Soc Nephrol 2009 ; 20 : 2055-2064.
PubMed
4. Bridoux F, et al. Diagnosis of monoclonal gammopathy of renal significance. Kidney Int 2015 ; 87 : 698-711.
PubMed
5. Sethi S, et al. Membranoproliferative glomerulonephritis : pathogenetic heterogeneity and proposal for a new classification. Semin Nephrol 2011 ; 31 : 341-348.
PubMed
6. Burkholder PM, et al. Mixed membranous and proliferative glomerulonephritis. A correlative light, immunofluorescence, and electron microscopic study. Lab Invest 1970 ; 23 : 459-479.
PubMed
7. Strife CF, et al. Type III membranoproliferative glomerulonephritis : long-term clinical and morphologic evaluation. Clin Nephrol 1984 ; 21 : 323-334.
PubMed
8. Anders D, et al. Basement membrane changes in membranoproliferative glomerulonephritis. II. Characterization of a third type by silver impregnation of ultra thin sections. Virchows Arch A Pathol Anat Histol 1977 ; 376 : 1-19.
PubMed
9. Pickering MC, et al. C3 glomerulopathy : consensus report. Kidney Int 2013 ; 84 : 1079-1089.
PubMed
10. Larsen CP, et al. Membranoproliferative glomerulonephritis with masked monotypic immunoglobulin deposits. Kidney Int 2015 ; 88 : 867-873.
PubMed
P.144 掲載の参考文献
1. Fakhouri F, et al. C3 glomerulopathy : a new classification. Nat Rev Nephrol 2010 ; 6 : 494-499.
PubMed
2. Sethi S, et al. Membranoproliferative glomerulonephritis and C3 glomerulopathy : resolving the confusion. Kidney Int 2012 ; 81 : 434-441.
PubMed
3. Pickering MC, et al. C3 glomerulopathy : consensus report. Kidney Int 2013 ; 84 : 1079-1089.
PubMed
4. Levy M, et al. Immunopathology of membranoproliferative glomerulonephritis with subendothelial deposits (Type I MPGN). Clin Immunol Immunopathol 1978 ; 10 : 477-492.
PubMed
5. Neary JJ, et al. Linkage of a gene causing familial membranoproliferative glomerulonephritis type III to chromosome 1. J Am Soc Nephrol 2002 ; 13 : 2052-2057.
PubMed
6. Servais A, et al. Primary glomerulonephritis with isolated C3 deposits : a new entity which shares common genetic risk factors with haemolytic uraemic syndrome. J Med Genet 2007 ; 44 : 193-199.
PubMed
7. Sibley RK, et al. Dense intramembranous deposit disease : New pathologic features. Kidney Int 1984 ; 25 : 660-670.
PubMed
8. Galle P, et al. Electron dense alteration of kidney basement membranes. A renal lesion specific of a systemic disease. Am J Med 1975 ; 58 : 749-764. Nephrology Frontier 2008 ; 7 : 42-45.
 
9. Appel GB, et al. Membranoproliferative glomerulonephritis type II (dense deposit disease) : an update. J Am Soc Nephrol 2005 ; 16 : 1392-1403.
PubMed
10. Sethi S, et al. Atypical postinfectious glomerulonephritis is associated with abnormalities in the alternative pathway of complement. Kidney Int 2013 ; 83 : 293-299.
PubMed
11. Aita K, et al. Early recurrence of dense deposit disease with marked endocapillary proliferation after renal transplantation. Pathol Int 2006 ; 56 : 101-109.
PubMed
12. Sethi S, et al. Dense deposit disease associated with monoclonal gammopathy of undetermined significance. Am J Kidney Dis 2010 ; 56 : 977-982.
PubMed
13. Joh K, et al. Morphologic variations of dense deposit disease : Light and electron microscopic, immunohistochemical and clinical findings in 10 patients. Acta Pathol Jpn 1993 ; 43 : 552-565.
PubMed
14. Walker PD, et al. Dense deposit disease is not a membranoproliferative glomerulonephritis. Mod Pathol 2007 ; 20 : 605-616.
 
15. Hou J, et al. Toward a working definition of C3 glomerulopathy by immunofluorescence. Kidney Int 2014 ; 85 : 450-456.
 
16. D'Agati VD, et al. C3 glomerulopathy : what's in a name? Kidney Int 2012 ; 82 : 379-381.
 
17. Ito N, et al. C3 glomerulopathy and current dilemmas. Clin Exp Nephrol : 2016 Nov 23. [Epub ahead of print]
 
18. Anders D, et al. Basement membrane changes in membranoproliferative glomerulonephritis. II. Characterization of a third type by silver impregnation of ultra thin sections. Virchows Arch A Pathol Anat Histol 1977 ; 376 : 1-19.
PubMed
P.153 掲載の参考文献
1. Petri M, et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 2012 ; 64 : 2677-2686.
PubMed
2. D'Agati VD. Renal disease in systemic lupus erythematosus, mixed connective tissue disease, Sjogren's syndrome, and rheumatoid arthritis, in Heptinstall's Pathology of the Kidney. Philadelphia : Lippincott Williams & Wilkins, 517-612, 2007.
 
3. Weening JJ, et al. The Classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int 2004 ; 65 : 521-530.
PubMed
4. Weening JJ, et al. The Classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 2004 ; 15 : 241-250.
PubMed
5. Austin HA 3rd, et al. Prognostic factors in lupus nephritis. Contribution of renal histologic data. Am J Med 1983 ; 75 : 382-391.
PubMed
6. Miyakis S, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006 ; 4 : 295-306.
 
7. Furness PN, et al. Interobserver reproducibility and application of the ISN/RPS classification of lupus nephritis-A UK-wide study. Am J Surg Pathol 2006 ; 30 : 1030-1035.
PubMed
8. Schwartz MM. The pathology of lupus nephritis. Semin Nephrol 2007 ; 27 : 22-34.
PubMed
9. Gerhardsson J, et al. Histological antiphospholipid-associated nephropathy versus lupus nephritis in patients with systemic lupus erythematosus : an observational cross-sectional study with longitudinal follow-up. Arthritis Res Ther 2015 ; 17 : 109.
PubMed
P.161 掲載の参考文献
1. Haneda M, et al. A new classification of diabetic nephropathy 2014 : a report from Joint Committee on Diabetic Nephropathy. Clin Exp Nephrol 2015 ; 19 : 1-5.
 
2. 糖尿病性腎症並びに腎硬化症の診断水準向上と重症化防止に向けた調査・研究研究班. 糖尿病性腎症と高血圧性腎硬化症の病理診断の手引き. 東京 : 東京医学社, 2015.
 
3. Sharma SG, et al. The modern spectrum of renal biopsy findings in patients with diabetes. Clin J Am Soc Nephrol 2013 ; 8 : 1718-1724, 2013.
PubMed
4. Ekinci EI, et al : Renal structure in normoalbuminuric and albuminuric patients with type 2 diabetes and impaired renal function. Diabetes Care 2013 ; 36 : 3620-3626.
PubMed
5. Kimmelstiel P, et al. Intercapillary lesions in the glomeruli of the kidney. Am J Pathol 1938 ; 12 : 83-98.
 
6. Yajima G. A histopathological study on diabetic nephropathy-Light and electron microscopic observations. Acta Pathol Jpn 1976 ; 26 : 47-62.
 
7. An Y, et al. Renal histologic changes and the outcome in patients with diabetic nephropathy. Nephrol Dial Transplant 2015 ; 30 : 257-266.
PubMed
8. Hoshino J, et al. A pathological scoring system to predict renal outcome in diabetic nephropathy. Am J Nephrol 2015 ; 41 : 337-344.
PubMed
9. Wen M, et al. Three-dimensional analysis of increased vasculature around the glomerular vascular pole in diabetic nephropathy. Virchows Archiv A Pathol Anat 1993 ; 423 : 201-207.
 
10. Mise K, et al. Clinical implication of linear immunofluorescent staining for immunoglobulin G in patients with diabetic nephropathy. Diabetes Res Clin Pract 2014 ; 106 : 522-530.
PubMed
11. Tervaert TW, et al. Pathologic classification of diabetic nephropathy. J Am Soc Nephrol 2010 ; 21 : 556-563.
PubMed
12. Mise K, et al. Renal prognosis a long time after renal biopsy on patients with diabetic nephropathy. Nephrol Dial Transplant 2014 ; 29 : 109-118.
PubMed
13. Oh SW, et al. Clinical implication of pathologic diagnosis and classification for diabetic nephropathy. Diabetes Res Clin Pract 2012 ; 97 : 418-4424.
PubMed
14. Raparia K, et al. Renal morphologic lesions reminiscent of diabetic nephropathy. Arch Pathol Lab Med 2013 ; 137 : 351-359.
PubMed
15. Markowitz GS, et al. Idiopathic nodular glomerulosclerosis is a distinct clinicopathologic entity linked to hypertension and smoking. Hum Pathol 2002 ; 33 : 826-835.
PubMed
16. Liang KV, et al. Nodular glomerulosclerosis : Renal lesions in chronic smokers mimic thrombotic microangiopathy and hypertensive lesions. Am J Kidney Dis 2007 ; 49 : 552-559.
PubMed
17. Salvatore SP, et al. Smoking-related glomerulopathy : Expanding the morphologic spectrum. Am J Nephrol 2015 ; 41 : 66-72.
PubMed
18. Cossey LN, et al. Defining the spectrum of immunoglobulin A-dominant/co-dominant glomerular deposition in diabetic nephropathy. Human Pathology 2014 ; 45 : 2294-2301.
 
P.167 掲載の参考文献
1. Sipe JD, et al. Amyloid fibril proteins and amyloidosis : chemical identification and clinical classification International Society of Amyloidosis 2016 Nomenclature Guidelines. Amyloid 2016 ; 23 : 209-213.
PubMed
2. Khalighi MA, et al. Amyloid nephropathy. Clin Kidney J 2014 ; 7 : 97-106.
PubMed
3. Sen S, et al. A proposed histopathologic classification, scoring, and grading system for renal amyloidosis : standardization of renal amyloid biopsy report. Arch Pathol Lab Med 2010 ; 134 : 532-544.
PubMed
4. Said SM, et al. Renal amyloidosis : origin and clinicopathologic correlations of 474 recent cases. Clin J Am Soc Nephrol 2013 ; 8 : 1515-1523.
PubMed
5. Picken MM. Proteomics and mass spectrometry in the diagnosis of renal amyloidosis. Clin Kidney J 2015 ; 8 : 665-672.
PubMed
P.173 掲載の参考文献
1. Rosenman E, et al. Nephrotic syndrome associated with amyloid-like glomerular deposits. Nephron 1997 ; 18 : 301-308.
 
2. Korbet SM, et al. Immunotactoid glomerulopathy. Medicine (Baltimore) 1985 ; 64 : 228-243.
PubMed
3. Schwartz MM, et al. Immunotactoid glomerulopathy. J Am Soc Nephrol 2002 ; 13 : 1390-1397.
PubMed
4. Alpers CE : Fibrillary glomerulonephritis and immunotactoid glomerulopathy : two entities, not one. Am J Kidney Dis 1993 ; 22 : 448-451.
 
5. Fogo A, et al. Morphologic and clinical features of fibrillary glomerulonephritis versus immunotactoid glomerulopathy. Am J Kidney Dis 1993 ; 22 : 367-377.
PubMed
6. 城謙輔. 免疫グロブリン関連蛋白沈着症. 伊藤克己, ほか (編), Annual Review 腎臓 2004. 75-91, 東京 : 中外医学社, 2004.
 
7. 城謙輔. イムノタクトイド糸球体症と線維性糸球体炎. Nephrology Frontier 2007 : 6 : 429-435.
 
8. Nasr SH, et al. Immunotactoid glomerulopathy : clinicopathologic and proteomic study. Nephrol Dial Transplant 2012 ; 27 : 4137-4146.
PubMed
9. Pronovost PH, et al. Clinical features, predictors of disease progression and results of renal transplantation in fibrillary/immunotactoid glomerulopathy. Nephrol Dial Transplant 1996 ; 11 : 837-842.
PubMed
10. Brady HR. Fibrillary glomerulopathy. Kidney Int 1998 ; 53 : 1421-1429.
PubMed
11. Rosenstock JL, et al. Fibrillary and immunotactoid glomerulonephritis : Distinct entities with different clinical and pathologic features. Kidney Int 2003 ; 63 : 1450-1461.
PubMed
12. Bridoux F, et al. Fibrillary glomerulonephritis and immunotactoid (microtubular) glomerulopathy are associated with distinct immunologic features. Kidney Int 2002 ; 62 : 1764-1775.
PubMed
13. Korbet SM, et al. The fibrillary glomerulopathies. Am J Kidney Dis 1994 ; 23 : 751-765.
PubMed
14. Joh K. Pathology of glomerular deposition diseases. Pathol Int 2007 ; 57 : 551-565.
PubMed
15. Ivanyi B, et al. Fibrillary glomerulonephritis and immunotactoid glomerulopathy. Nephrol Dial Transplant 2004 ; 19 : 2166-2170.
 
16. Herrera GA, et al. Renal diseases with organized deposits : an algorithmic approach to classification and clinicopathologic diagnosis. Arch Pathol Lab Med 2010 ; 134 : 512-531.
PubMed
17. Risca VI, et al. Actin filament curvature biases branching direction. Proc Natl Acad Sci USA 2012 ; 109 : 2913-2918.
PubMed
18. Sethi S, et al. Laser microdissection and mass spectrometry-based proteomics aids the diagnosis and typing of renal amyloidosis. Kidney Int 2012 ; 82 : 226-234.
PubMed
P.176 掲載の参考文献
1. Heidet L, et al. In vivo expression of putative LMX1B targets in Nail-Patella syndrome kidneys. Am J Pathol 2003 ; 163 : 145-155.
PubMed
2. Lemley KV. Kidney disease in nail-patella syndrome. Pediatr Nephrol 2009 : 24 : 2345-2354.
PubMed
3. Harita Y, et al. Spectrum of LMX1B mutations : from nail-patella syndrome to isolated nephropathy. Pediatr Nephrol 2016. [Epub ahead of print]
 
4. Arakawa M, et al. Collagenofibrotic glomerulonephropathy : A new type of primary glom erulonephropathy revealing massive collagen deposition in the renal glomerulus. Niigata : Nishimura Co., Ltd, 1991.
 
5. Ikeda K, et al. Primary glomerular fibrosis : A new nephropathy caused by diffuse intra-glomerular increase in atypical type III collagen fibers. Clin Nephrol 1990 ; 33 : 155-159.
PubMed
6. Duggal R, et al. Collagenofibrotic glomerulopathy-a review. Clin Kidney J 2012 ; 5 : 7-12.
PubMed
P.181 掲載の参考文献
1. Trendelenburg M, et al. Cryoglobulins are not essential. Ann Rheum Dis 1998 ; 57 : 3-5.
 
2. Cacoub P, et al. Cryoglobulinemia Vasculitis. Am J Med 2015 ; 128 : 950-955.
PubMed
3. 城謙輔. クリオグロブリン血症性血管炎・糸球体腎炎. Nephrol Fronti 2007 ; 6 : 57-61.
Medical*Online
4. Johnson RJ, et al. Membranoproliferative Glomerulonephritis Associated with Hepatitis C Virus Infection. N Engl J Med 1993 ; 328 : 465-470.
PubMed
5. Braun GS, et al. Cryoglobulinaemic vasculitis : classification and clinical and therapeutic aspects. Postgrad Med J 2007 ; 83 : 87-94.
PubMed
6. Colvin RB, et al. Mixed cryoglobulinemic glomerulonephritis and Type I cryoglobulinemic glomerulonephritis, Colvin RB, et al (eds). Diagnostic pathology : Kidney Diseases, 2nd ed, 174, 175, 212-215, US : Elsevier. 2015.
 
7. Touchard G. Ultrastructural pattern and classification of renal monoclonal immunoglobulin deposits. Touchard G, et al. Monoclonal gammopathies and the kidney, 1st ed, 108-117, Germany : Springer Netherlands, 2003.
 
8. 上杉憲子. クリオグロブリン血症性糸球体腎炎の診断. 腎と透析 2014 ; 77 : 199-206.
Medical*Online
P.188 掲載の参考文献
1. Santostefano M, et al. The ultrastructural basis of renal pathology in monoclonal gammopathies. J Nephrol 2005 ; 18 : 659-675.
PubMed
2. Nasr SH, et al. Proliferative glomerulonephritis with monoclonal IgG deposits : a distinct entity mimicking immune-complex glomerulonephritis. Kidney Int 2004 ; 65 : 85-96.
PubMed
3. Komatsuda A, et al. Proliferative glomerulonephritis with monoclonal immunoglobulin light chain deposits : a rare entity mimicking immune-complex glomerulonephritis. Intern Med 2012 ; 51 : 3273-3276.
PubMed
4. Preud'homme JL, et al. Monoclonal immunoglobulin deposition disease ( Randall type). Relationship with structural abnormalities of immunoglobulin chains. Kidney Int 1994 ; 46 : 965-972.
PubMed
5. 涌井秀樹, ほか. 単クローン性軽鎖重鎖沈着病. 直江知樹, ほか (編). WHO血液腫瘍分類～WHO分類2008をうまく活用するために～. 335-338, 東京 : 医薬ジャーナル社, 2010.
 
6. Buxbaum JN, et al. Monoclonal immunoglobulin deposition disease : light chain and light and heavy chain deposition diseases and their relation to light chain amyloidosis. Clinical features, immunopathology, and molecular analysis. Ann Intern Med 1990 ; 112 : 455-464.
PubMed
7. Masai R, et al. Clinicopathological features and prognosis in immunoglobulin light and heavy chain deposition disease. Clin Nephrol 2009 ; 71 : 9-20.
PubMed
8. Oe Y, et al. A case of γ1-heavy chain deposition disease successfully treated with melphalan and prednisolone therapy. Intern Med 2010 ; 49 : 1411-1415.
 
9. Kourelis TV, et al. Outcomes of patients with renal monoclonal immunoglobulin deposition disease. Am J Hematol 2016 ; 91 : 1123-1128.
PubMed
10. Ronco P, et al. Immunoglobulin ligh (t heavy) -chain deposition disease : from molecular medicine to pathophysiology-driven therapy. Clin J Am Soc Nephrol 2006 ; 1 : 1342-1350.
 
11. Nasr SH, et al. Proliferative glomerulonephritis with monoclonal IgG deposits. J Am Soc Nephrol 2009 ; 20 : 2055-2064.
PubMed
12. 涌井秀樹, ほか. Proliferative glomerulonephritis with monoclonal IgG deposits. 腎臓症候群 (上) 第2版. 47-51, 東京 : 日本臨牀社, 2011.
 
P.194 掲載の参考文献
1. Nasr SH, et al. Proliferative glomerulonephritis with monoclonal IgG deposits : a distinct entity mimicking immune-complex glomerulonephritis. Kidney Int 2004 ; 65 : 85-96.
PubMed
2. Alpers CE, et al. Single light chain subclass (kappa chain) immunoglobulin deposition in glomerulonephritis. Human Pathol 1985 ; 3 : 294-304.
PubMed
3. Nasr SH, et al. Proliferative glomerulonephritis with monoclonal IgG deposits. J Am Soc Nephrol 2009 ; 20 : 2055-2064.
PubMed
4. Guiard E, et al. Patterns of noncryoglobulinemic glomerulonephritis with monoclonal Ig deposits : correlation with IgG subclass and response to rituximab. Clinical J Am Soc Nephrol 2011 ; 6 : 1609-1616.
 
5. Masai R, et al. Clinicopathological features and prognosis in immunoglobulin light and heavy chain deposition disease. Clin Nephrol 2009 ; 71 : 2-20.
 
6. Soares SM, et al. A proliferative glomerulonephritis secondary to a monoclonal IgA. Am J Kidney Dis 2006 ; 47 : 342-349.
 
7. Sasaki H, et al. Proliferative glomerulonephritis with monoclonal immunoglobulin deposits : a poorly-understood disease spectrum. J Nephrol Ther. doi : 10.4172/2161-0959.1000e116.
 
8. Yahata M, et al. Proliferative glomerulonephritis with monoclonal IgM deposits without Waldenstrom's macroglobulinemia : case report and review of the literature. Clin Nephrol 2012 ; 77 : 254-260.
PubMed
P.200 掲載の参考文献
1. Strom EH, et al. Glomerulopathy associated with predominant fibronectin deposits : a newly recognized hereditary disease. Kidney Int 1995 ; 48 : 163-170.
PubMed
2. Burgin M, et al. Familial glomerulopathy with giant fibrillar deposits. Virchows Arch A Pathol Anat Histol 1980 ; 388 : 313-326.
PubMed
3. Castelletti F, et al. Mutations in FN1 cause glomerulopathy with fibronectin deposits. Proc Natl Acad Sci USA 2008 ; 105 : 2538-2543.
PubMed
4. Niimi K, et al. Fibronectin glomerulopathy with nephrotic syndrome in a 3-year-old male. Pediatr Nephrol 2002 ; 17 : 363-366.
 
5. 上杉憲子, ほか. Fibronectin Glomerulopathy 4家系5症例の臨床病理学的特徴と形態学的検討. 日腎会誌 1999 ; 41 : 49-59.
 
6. Gemperle O, et al. Familial glomerulopathy with giant fibrillar (fibronectin-positive) deposits : 15-year follow-up in a large kindred. Am J Kidney Dis 1996 ; 28 : 668-675,.
 
7. 大坪裕美, ほか. フィブロネクチン腎症について. 日児腎誌 2016 ; 29 : 137-141.
 
8. Ohtsubo H, et al. Identification of mutations in FN1 leading to glomerulopathy with fibronectin deposits. Pediatr Nephrol 2016 ; 31 : 1459-1467.
PubMed
9. Otsuka Y, et al. A recurrent fibronectin glomerulopathy in a renal transplant patient : a case report. Clin Transplant 2012 ; 26 (Suppl 24) : 58-63.
 
10. Van Vliet A, et al. Distribution of fibronectin isoforms in human renal disease. J Pathol 2001 ; 193 : 256-262.
PubMed
P.202 掲載の参考文献
1. Saito T, et al. Lipoprotein glomerulopathy : glomerular lipoprotein thrombi in a patient with hyperlipoproteinemia. Am J Kidney Dis 1989 ; 13 : 148-153.
 
2. Churg J, et al. Liporotein glomerulopathy in Classification of glomerular disease. In Renal Disease, 2nd edition, New York, Tokyo : Igakushoin 1995 : 450-457.
 
3. Saito T, et al. Impact of lipoprotein glomerulopathy on the relationship between lipids and renal disease. Am J Kid Dis 2006 ; 47 : 199-211.
PubMed
P.208 掲載の参考文献
1. MoriniereV, et al. Improving mutation screening in familial hematuric nephropathies through next generation sequencing. J Am Soc Nephrol 2014 ; 25 : 2740-2751.
PubMed
2. Kamiyoshi N, et al. Genetic, clinical, and pathologic backgrounds of patients with autosomal dominant Alport syndrome. Clin J Am Soc Nephrol 2016 ; 11 : 1441-1449.
PubMed
3. Hashimura Y, et al. Milder clinical aspects of X-linked Alport syndrome in men positive of the collagen IV α5 chain. Kidney Int 2014 ; 85 : 1208-1213.
 
4. Oka M, et al. Natural history of genetically proven autosomal recessive Alport syndrome. Pediatr Nephrol 2014 ; 29 : 1535-1544.
PubMed
5. 岡政史, ほか. 常染色体性Alport症候群. 日小児腎臓病会誌 2010 ; 23 : 8-12.
 
6. 中西浩一, ほか. Alport症候群. 日腎会誌 2015 ; 57 : 736-742.
 
7. Tryggvason K, et al. Thin basement membrane nephropathy. J Am Soc Nephrol 2006 ; 17 : 813-822.
PubMed
8. Hennigar RA, et al. Glomerular diseases associated primarily with asymptomatic or gross hematuria. Zhou XJ, et al (ed). Diagnostic Renal Pathology. 127-177, New York : Cambridge University Press, 2009.
 
9. Haas M. Alport syndrome thin glomerular basement membrane nephropathy : a practical approach to diagnosis. Arch Pathol Lab Med 2009 ; 113 : 224-232.
 
P.214 掲載の参考文献
1. Jenette JC. The nephrotic syndrome. Jenette JC, et al (ed). Heptinstall's pathology of the kidney. Philadelphia : Lippincott-Raven, 1998 ; 187-258.
 
2. Patrakka J, et al. Congenital nephrotic syndrome of the Finnish type (NPHS1) : features resulting from different nephrin mutations in different patients. Kidney Int 2000 ; 58 : 972-980.
PubMed
3. Kestilaa M, et al. Positionally cloned gene for a novel glomerular protein-nephrin-is mutated in congenital nephrotic syndrome. Mol Cell 1998 ; 1 : 575-582.
 
4. Lenkkeri U, et al. Structure of the gene for congenital nephrotic syndrome of the Finnish type (NPHS1) and characterization of mutations. Am J Hum Genet 1999 ; 64 : 51-61.
PubMed
5. Habib R, et al. Diffuse mesangial sclerosis : a congenital glomerulopathy with nephrotic syndrome. Adv Nephrol Necker Hosp 1993 ; 22 : 43.
PubMed
6. Habib R, et al. The nephropathy associated with male pseudohermaphroditism and Wilms' tumor (Drash syndrome) : adistinctive glomerular lesion-report of 10 cases. Clin Nephrol 1985 ; 24 : 269-278.
 
7. Schumacher V, et al. Spectrum of early onset nephrotic syndrome associated with WT1 missense mutations. Kidney Int 1998 ; 53 : 1594-1600.
PubMed
8. Patek CE, et al. A zinc finger truncation of murine WT1 results in the characteristic urogenital abnormalities of Denys-Drash syndrome. Proc Natl Acad Sci 1999 ; 96 : 2931-2936.
PubMed
9. Ogata K, et al. So-called embryonal hyperplasia of Bowman's capsular epithelium : an immunohistochemical and ultrastructural study. Virchows Arch A Pathol Anat Histopathol 1991 ; 418 : 143-147.
 
10. Zenker M, et al. Human laminin beta2 deficiency causes congenital nephrosis with mesangial sclerosis and distinct eye abnormalities. Hum Mol Genet 2004 ; 13 : 2625-2632.
PubMed
P.218 掲載の参考文献
1. Pisani A, et al. The kidney in Fabry's disease. Clin Gnet 2014 ; 86 : 301-309.
 
2. Fabry J. Ein Beitrag zur Kenntnis der Purpura haemorrhagica nodularis (Purpura haemorrhagica Hebrae). Arch Dermatol Syphilol 1898 ; 43 : 187.
 
3. Anderson W. A case of angiokeratoma. Br J Dermatol 1898 ; 10 : 113.
 
4. Waldek S, Feriozzi S. Fabry nephropathy : a review-how can we optimize the management of Fabry nephropathy? BMC nephropathy 2014 ; 15 : 72. doi : 10.1186/1471-2369-15-72.
 
5. Thurberg B, et al. Globotriaosylceramide accumulation in the Fabry kidney is cleared from multiple cell types after enzyme replacement therapy. Kidney Int 2002 ; 62 : 1933-1946.
PubMed
6. Alroy J, et al. Renal pathology in Fabry disease. J Am Soc Nephrol 2002 ; 13 : S134-138.
PubMed
7. Najafian B, et al. AJKD atlas of renal pathology : Fabry nephropathy. Am J Kidney Dis 2015 ; 66 : e35-e36.
PubMed
8. Fogo AB, et al. Scoring system for renal pathology in Fabry disease : report of the International Study Group of Fabry Nephropathy (ISGFN). Nephrol Dial Transplant 2010 ; 25 : 2168-2177.
 
9. Valbuena C, et al. Kidney biopsy findings in heterozygous Fabry disease females with early nephropathy. Virchows Arch 2008 ; 453 : 329-338.
PubMed
10. Fischer EG, et al. Fabry disease : a morphological study of 11 cases. Mod Path 2016 ; 19 : 1295-1301.
 
11. Hunley TE, et al. Nephrotic syndrome complicating alpha-glucosidase replacement therapy for Pompe disease. Pediatrics 2004 ; 114 : 532-535.
 
P.222 掲載の参考文献
1. Leonard JV, et al. Mitochondrial respiratory chain disorder I. mitochondrial DNA defects. Lancet 2000 ; 355 : 299-304.
 
2. Finsterer J. Mitochondriopathies. Eur J Neurol 2004 ; 11 : 163-186.
PubMed
3. Niaudet P, et al. The kidney in mitochondrial cytopathies. Kidney Int 1997 ; 51 : 1000-1007.
PubMed
4. Roetig A. Renal disease and mitochondrial genetics. J Nephrol 2003 ; 16 : 286-292.
PubMed
5. Emma F, et al. Renal mitochondrial cytopathies. Int J Nephrol 2011, Article ID 609213.
 
6. Jansen JJ, et al. Mutation in mitochondrial tRNALeu (UUR) gene associated with progressive kidney disease. J Am Soc Nephrol 1997 ; 8 : 1118-1124.
PubMed
7. Quinzii C, et al. A mutation in para-hydroxybenzoate-polyprenyl transferase (COQ2) causes primary coenzyme Q10 deficiency. Am J Hum Genet 2004 ; 78 : 345-349.
 
8. Kobayashi A, et al. Granular swollen epithelial cells : a histologic and diagnostic marker for mitochondrial nephropathy. Am J Surg Pathol 2010 ; 34 : 262-270.
PubMed
9. Imasawa T, et al. Pathological similarities between low birth weightrelated nephropathy and nephropathy associated with mitochondrial cytopathy. Diagnostic Pathology 2014 ; 9 : 181.
PubMed

各論 : 感染関連腎炎

P.227 掲載の参考文献
1. Jenett JC, et al : Acute poststreptococcal glomerulonephritis. Pathology of the kidney. 7th ed. 367-404, Philadelphia : Lippincott Williams & Wilkins, 2015.
 
2. D'Agati VD, et al. Acute postinfectious glomerulonephritis and acute diffuse proliferative glomerulonephritis. Atlas of Nontumor Pathology First Ser. No4, Non-Neoplatic Kidney Disease, AFIP 269-283, Maryland : Silver Spring, 2005.
 
3. Colvin RB, et al. Acute poststreptococcal glomerulonephritis. Kidney Diseases. 2nd ed. 294-301, Elsevier, Manitoba, 2016.
 
4. 上田善彦, ほか : 管内性糸球体病変を伴う糸球体疾患. 病理と臨床 2001 ; 19 : 966-972.
Medical*Online
5. Yoshizawa N, et al. Nephritis-associated plasmin receptor and acute poststreptococcal glomerulonephritis : characterization of the antigen and associated immune response. J Am Soc Nephrol 2004 ; 15 : 1785-1793.
PubMed
6. Oda T, et al. Glomerular plasmin-like activity in relation to nephritis-associated plasmin receptor in acute poststreptococcal glomerulonephritis. J Am Soc Nephrol 2005 ; 16 : 247-254.
PubMed
7. Suga K, et al. A case of dense deposit disease associated with a group A streptococcal infection without the involvement of C3NeF or complement factor H deficiency. Pediatr Nephrol 2010 ; 25 : 1547-1550.
PubMed
8. Okabe M, et al. A case of idiopathic membranoproliferative glomerulonephritis with a transient glomerular deposition of nephritis-associated plasmin receptor antigen. Clin Exp Nephrol 2012 ; 16 : 337-341.
PubMed
9. Kikuchi Y, et al. Streptococcal origin of a case of Henoch-Schoenlein purpura nephritis. Clin Nephrol 2006 ; 65 : 124-128.
PubMed
10. Odaka J, el al. A case of post-pneumococcal acute glomerulonephritis with glomerular depositions of nephritis-associated plasmin receptor. CEN Case Rep 2015 ; 4 : 112-116.
 
11. 尾田高志. 感染関連糸球体腎炎に関する最近の知見. 東医大誌 2015 ; 73 : 355-363.
Medical*Online
P.234 掲載の参考文献
1. Nasr SH, et al. Bacterial infection-related glomerulonephritis in adults. Kidney Int 2013 ; 83 : 792-803.
PubMed
2. Satoskar AA, et al. Staphylococcus infection-associated glomerulonephritis mimicking IgA nephropathy. Clin J Am Soc Nephrol 2006 ; 1 : 1179-1186.
PubMed
3. Nasr SH, et al. IgA-dominant postinfectious glomerulonephritis : a new twist on an old disease. Nephron Clin Pract 2011 ; 119 : c18-25.
 
4. Glassock RJ, et al. Staphylococcus-related glomerulonephritis and poststreptococcal glomerulonephritis : why defining "post" is important in understanding and treating infection-related glomerulonephritis. Am J Kidney Dis 2015 ; 65 : 826-832.
PubMed
5. Satoskar AA, et al. Staphylococcus Infection-Associated GN-Spectrum of IgA Staining and Prevalence of ANCA in a Single-Center Cohort. Clin J Am Soc Nephrol 2017 ; 12 : 39-49.
 
6. Wang SY, et al. Clinical, Pathological, and Prognostic Characteristics of Glomerulonephritis Related to Staphylococcal Infection. Medicine (Baltimore) 2016 ; 95.
PubMed
7. Koyama A, et al. Glomerulonephritis associated with MRSA infection : a possible role of bacterial superantigen. Kidney Int 1995 ; 47 : 207-216.
PubMed
8. Satoskar AA, et al. Henoch-Schonlein purpura-like presentation in IgA-dominant Staphylococcus infection-associated glomerulonephritis-a diagnostic pitfall. Clin Nephrol 2013 ; 79 : 302-312.
PubMed
9. Boils CL, et al. Update on endocarditis-associated glomerulonephritis. Kidney Int 2015 ; 87 : 1241-1249.
PubMed
10. 城謙輔. 細菌感染に伴う免疫複合体型糸球体腎炎群. Nephrol Fronti 2008 ; 7 : 55-63.
Medical*Online
11. 小川弥生. 感染症に関連する糸球体腎炎. 病理と臨床 2016 ; 34 : 1279-1285.
Medical*Online
12. Rogers TE, et al. Glomerular disease associated with nephritic syndrome and/or rapidly progressive glomerulonephritis in Silva's Diagnostic Renal Pathology. Silva FG (ed). 178-228, New York : Cambridge University Press, 2009.
 
13. 白井信男, ほか. V-Aシャント術後に発症したMPGN (いわゆるshunt nephritis) の1剖検例. 腎と透析 1980 : 8 : 609-614.
 
P.239 掲載の参考文献
1. Waldman M, et al. Parvovirus B19 and the kidney. Clin J Am Soc Nephrol 2007 ; 2 Suppl 1 : S47-56.
 
2. 熊野 浩. ヒトパルボウイルスB19感染症のさまざまな病態. 日臨免疫会誌 2008 ; 31 : 448-453.
 
3. Kupin WL. Viral-Associated GN : Hepatitis B and Other Viral Infections. Clin J Am Soc Nephrol 2016.
PubMed
4. D'Agati V, et al. Renal pathology of human immunodeficiency virus infection. Semin Nephrol 1998 ; 18 : 406-421.
PubMed
5. 原正, ほか.【腎疾患をもたらす感染症】HIV関連腎臓病. 腎と透析 2014 ; 76 : 345-348.
 
6. Fogo AB, et al. AJKD Atlas of Renal Pathology : HIV-Associated Nephropathy (HIVAN). Am J Kidney Dis 2016 ; 68 : e13-14.
PubMed
7. Fogo AB, et al. AJKD Atlas of Renal Pathology : HIV-Associated Immune Complex Kidney Disease (HIVICK). Am J Kidney Dis 2016 ; 68 : e9-e10.
PubMed
8. Gervasoni C. Thrombotic microangiopathy in patients with acquired immunodeficiency syndrome before and during the era of introduction of highly active antiretroviral therapy. Clin Infect Dis 2002 ; 35 : 1534-1540.
PubMed
9. Utz JP, et al. Clinical and Laboratory Studies of Mumps. N Engl J Med 1964 ; 270 : 1283-1286.
PubMed
P.246 掲載の参考文献
1. Gupta A, et al. Glomerular Diseases Associated With Hepatitis B and C. Adv Chronic Kidney Dis 2015 ; 22 : 343-351.
 
2. 島田美智子, ほか. 腎疾患をもたらす感染症肝炎ウイルス関連腎症. 腎と透析 2014 ; 76 : 390-398.
 
3. Bhimma R, et al. Hepatitis B virus-associated nephropathy. Am J Nephrol 2004 ; 24 : 198-211.
PubMed
4. Ozkok A, et al. Hepatitis C virus associated glomerulopathies. World J Gastroenterol 2014 ; 20 : 7544-7554.
PubMed
5. Xie Q, et al. Renal phospholipase A2 receptor in hepatitis B virus-associated membranous nephropathy. Am J Nephrol 2015 ; 41 : 345-353.
PubMed
6. Fabrizi F, et al. Hepatitis C virus infection, mixed cryoglobulinemia, and kidney disease. Am J Kidney Dis 2013 ; 61 : 623-637.
PubMed
7. Tissandie E, et al. Both IgA nephropathy and alcoholic cirrhosis feature abnormally glycosylated IgA1 and soluble CD89-IgA and IgG-IgA complexes : common mechanisms for distinct diseases. Kidney Int 2011 ; 80 : 1352-1363.
PubMed
8. Adebayo D, et al. Renal dysfunction in cirrhosis is not just a vasomotor nephropathy. Kidney Int 2015 ; 87 : 509-515.
 
9. Kim JY, et al. The variable pathology of kidney disease after liver transplantation. Transplantation 2010 ; 89 : 215-221.
PubMed

各論 : 血管病変

P.253 掲載の参考文献
1. Zuccala A, et al. Is nephroangiosclerosis a hypertensin-induced nephropathy? Contrib Nephrol 1996 ; 119 : 110-114.
 
2. Bohle A, et al. The cempensated and the decompensated form of beneign nephrosclerosis. Pathol Res Prac 1982 ; 174 : 357.
 
3. 内藤隆, ほか. 腎硬化症. 腎と透析 1998 ; 45 (増刊) : 504-508.
 
4. Olson JL. Renal diseases due to hypertension. Jannete JC, et al (ed). In : Pathology of the kidney. 6th ed. 937-990, Philadelphia : Lippincott, 2007.
 
5. Freedman BI, et al. The link between hypertension and nephrosclerosis. Am J Kidney Dis 1995 ; 25 : 207-221.
PubMed
6. Ninomiya T, et al. Prehypertension increases the risk for renal arteriosclerosis in autopsies : the Hisayama Study. J Am Soc Nephrol 2007 ; 18 : 2135-2142.
PubMed
P.260 掲載の参考文献
1. Jennette JC, et al. 2012 Revised international Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 2013 ; 65 : 1-11.
 
2. Jennette JC, et al. Renal involvement in polyarteritis nodosa, Kawasaki disease, Takayasu arteritis, and giant cell arterisis. Jennette JC, et al (ed). In : Heptinstall's pathology of the kidney 7th ed. 685-709, Philadelphia : Wolters Kluwer, 2015.
 
3. 由谷親夫. 炎症性動脈疾患. 心臓血管病理アトラス, 253-263, 東京 : 文光堂, 2002.
 
4. 宮崎龍彦. 血管炎症候群の形態学的診断tips. 診断病理 2016 ; 33 : 19-37.
Medical*Online
5. Masuda M, et al. Pathological features of classical polyarteritis nodosa : Analysis of 19 autopy cases. Pathol Res Pract 2013 ; 209 : 161-166.
 
6. Takahashi K, et al. Kawasaki disease : basic and pathological findings. Clin Exp nephrol 2013 ; 17 : 690-693.
PubMed
7. Pillebout E, et al. Henoch-Schonlein Purpura in adults : outcome and prognostic factors. J Am Soc Nephrol 2002 ; 13 : 1271-1278.
PubMed
8. Akpolat T, et al. Renal Behcet's disease : an update. Semin Arthritis Rheum 2008 ; 38 : 241-248.
PubMed
9. D'Agati VD, et al. Renal disease in systemic lupus erythematosus, mixed connective tissue disease, Sjogren syndrome, and rheumatoid arthritis. Jennette JC, et al (ed). In : Heptinstall's pathology of the kidney 7th ed. 559-656, Philadelphia : Wolters Kluwer, 2015.
 
P.265 掲載の参考文献
1. Jennette JC, et al. 2012 Revised international Chapel Hill Consensus Conference Nomenclature of Vasculitis. Arthritis Rheum 65 ; 1-11 : 2013.
 
2. Jennette JC, et al. Small vessel vasculitis. N Engl J Med 1997 ; 337 : 1512-1523.
PubMed
3. Fujimoto S, et al. Comparison of the epidemiology of anti-neutrophil cytoplasmic antibody-associated vasculitis between Japan and UK. Rheumatol 2011 ; 50 : 1916-1920.
 
4. Ono N, et al. Characteristics of MPO-ANCA-positive granulomatosis with polyangiitis : a retrospective multi-center study in Japan. Rheumatol Int 2015 ; 35 : 555-559.
PubMed
5. Berden AE, et al. Histologic classification of ANCA-associated glomerulonephritis. J Am Soc Nephrol 2010 ; 21 : 1628-1636.
PubMed
6. Rahmattulla C, et al. Histopathological classification of antineutrophili cytoplasmic antibody-associated glomerulonephritis : an update. Curr Opin Nephrol Hypertens 2014 ; 23 : 224-231.
 
7. Jennette JC, et al. Pauci-immune and antineutrophil cytoplasmic autoantibody-mediated crescentic glomerulonephritis and vasculitis. Jennette JC, et al (ed), In : Heptinstall's Pathology of the Kidney 7th ed. 685-709, Philadelphia : Wolters Kluwer, 2015.
 
8. Bonsib SM, et al. Necrotizing medullary lesions in patients with ANCA associated renal disease. Mod Pathol 1994 ; 7 : 181-185.
PubMed
9. Haas M, et al, Immune complex deposits in ANCA-associated crescentic glomerulonephritis : a study of 126 cases. Kidney Int 2004 ; 65 : 2145-2152.
PubMed
P.272 掲載の参考文献
1. Barbour T, et al. Thrombotic microangiopathy and associated renal disorders. Nephrol Dial Transplant 2012 ; 27 : 2673-2685.
PubMed
2. 非典型溶血性尿毒症症候群診断基準改訂委員会, ほか (編). 非典型溶血性尿毒症症候群 (aHUS) 診療ガイド 2015. 日腎会誌 2016 ; 58 : 62-75.
 
3. Bu F, et al. Comprehensive genetic analysis of complement and coagulation genes in atypical hemolytic uremic syndrome. J Am Soc Nephrol 2014 ; 25 : 55-64.
PubMed
4. Warwicker P, et al. Genetic studies into inherited and sporadic hemolytic uremic syndrome. Kidney Int 1998 ; 53 : 836-844.
PubMed
5. Furlan M, et al. Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura. Blood 1997 ; 89 : 3097-3103.
PubMed
6. Bienaime F, et al. Antiphospholipid syndrome and kidney disease. Kidney Int 2017 ; 91 : 34-44.
PubMed
7. Fukuda K, et al. A case of secondary focal glomerulosclerosis associated with malignant hypertension. Clin Exp Nephrol Case Reports 2013 ; 2 : 68-75.
 
8. Le Quintrec M, et al. Complement mutation-associated de novo thrombotic microangiopathy following kidney transplantation. Am J Transplant 2008 ; 8 : 1694-1701.
PubMed
9. Borg M, et al. Renal toxicity after total body irradiation. Int J Radiat Oncol Biol Phys 2002 ; 54 : 1165-1173.
PubMed
10. Eremina V, et al. VEGF inhibition and renal thrombotic microangiopathy. N Engl J Med 2008 ; 358 : 1129-1136.
PubMed
11. Vigneau C, et al. All anti-vascular endothelial growth factor drugs can induce 'pre-eclampsia-like syndrome' : a RARe study. Nephrol Dial Transplant 2014 ; 29 : 325-332.
PubMed
P.276 掲載の参考文献
1. Laszik ZG et al. Thrombotic microangiopathies. Jennette JC, et al (ed). In : Pathology of the kidney. 7th ed. 739-814, Philadelphia : Wolters Kluwer, 2015.
 
2. Kambhan N. Scleroderma renal disease. Colvin RB, et al (ed). In : Diagnostic pathology. Kidney diseases. 544-549, Philadelphia : Elsevier, 2016.
 
3. Bose N, et al. Scleroderma renal crisis. Semin Arthritis Rheum 2015 ; 44 : 687-694.
PubMed
4. Steen VD. Kidney involvement in systemic sclerosis. Presse Med 2014 ; 43 : e305-314.
PubMed
5. Cunningham J, et al. Case records of the Massachusetts General Hospital. Case 30-2011. A 62-year-old woman with renal failure. N Engl J Med 2011 ; 365 : 1233-1243.
PubMed
6. Hashimoto A. Clinical features of 405 Japanese patients with systemic sclerosis. Mod Rheumatol 2012 ; 22 : 272-279.
PubMed
7. Hudson M, et al. Exposure to ACE inhibitors prior to the onset of scleroderma renal crisis-results from the International Scleroderma Renal Crisis Survey. Semin Arthritis Rheum 2014 ; 43 : 666-672.
 
8. Steen VD, et al. Long-term outcomes of scleroderma renal crisis. Ann Intern Med 2000 ; 133 : 600-603.
PubMed
9. Arnaud L, et al. ANCA-related crescentic glomerulonephritis in systemic sclerosis : revisiting the "normotensive scleroderma renal crisis". Clin Nephrol 2007 ; 68 : 165-170.
PubMed
P.282 掲載の参考文献
1. Flory CM. Arterial occlusions produced by emboli from eroded aortic atheromatous plaques. Am J Pathol 1945 ; 21 : 549-565.
PubMed
2. Scolani F, et al. Atheroembolic renal disease. Lancet 2010 ; 375 : 1650-1660.
 
3. Bell SP, et al. Cholesterol emboli syndrome-uncommon or unrecognized? J R Soc Med 1997 ; 90 : 543-546.
PubMed
4. Mittal BV, et al. Atheroembolic renal disease : A silent masquerader. Kidney Int 2008 ; 73 : 126-130.
PubMed
5. Sekhar CC, et al. Cholestrol Emboli Syndrome : Acute Renal Insufficiency After a Procedure or a Thrombolytic Therapy or Anticoagulant Therapy. Indian J Surg 2013 ; 75 (Suppl 1) : S432-S435.
 
6. Dupont PJ, et al. Cholesterol emboli syndrome. BMJ 2000 ; 321 : 1065-1067.
PubMed
7. Keddis MT, et al. Ischaemic nephropathy secondary to atherosclerotic renal artery stenosis : clinical and histopathological correlates. Nephrol Dial Transplant 2010 ; 25 : 3615-3622.
PubMed
8. 大西泰彦. コレステロール結晶塞栓症 (Cholesterol crystal embolization : CCE) の臨床・病理学的検討 皮膚・病理所見の推移と早期診断における皮膚生検の重要性について. 東邦医会誌 2001 ; 48 : 435-443.
Medical*Online
9. Pliquett RU, et al. Cholesterol-crystal embolism presenting with delayed graft function and impaired long-term function in renal transplant recipients : two case reports. J Med Case Rep 2009 ; 3 : 6839.
PubMed
10. Pirson Y, et al. Cholesterol embolism in a renal graft after treatment with streptokinase. BMJ 1988 ; 296 : 394-395.
 
11. Ahmed W, et al. An Unusual Case of a Patient who Lost His Native Kidneys and Renal Allograft from Cholesterol Crystal Emboli . Saudi J Kidney Dis Transpl 2015 ; 26 : 966-969.
PubMed
12. Peat DS, et al. Cholesterolembolimay mimic systemicvasculitis. BMJ 1996 ; 313 : 546-547.
PubMed

各論 : 尿細管間質性病変

P.289 掲載の参考文献
1. ACUTE KIDNEY INJURY, KDIGO [Internet]. [cited 2017 Jan 20] Available from : http:/kdigo.org/home/guidelines/acute-kidney-injury/
 
2. Kobayashi A, et al. Medullary ray injury in renal allografts. Pathol Int 2010 ; 60 : 744-749.
PubMed
3. Brodsky SV, et al. Acute kidney injury during warfarin therapy associated with obstructive tubular red blood cell casts : a report of 9 cases. AmJ K idney Dis 2009 ; 54 : 1121-1126.
 
4. Brodsky SV. Anticoagulants and acute kidney injury : clinical and pathology considerations. Kidney Res Clin Pract 2014 ; 33 : 174-180.
PubMed
5. Narasimha Krishna V, et al. Oral anticoagulants and risk of nephropathy. Drug Saf 2015 ; 38 : 527-533.
PubMed
6. Jennette CJ, et al (ed). Fig. 26.3. Heptinstall's pathology of the kidney 7th ed. 1176, Wolters Kluwer, 2015.
 
P.294 掲載の参考文献
1. The World Health Organization Collaborating Center for the Histological Classification for Renal Diseases. Churg J, et al (ed). Classification and atlas of tubule-interstitial diseases. In : Renal disease, Tokyo : Igaku-shoin, 1985.
 
2. Goicoechea M, et al. Spanish Registry of Glomerulonephritis. Increased prevalence of acute tubulointerstitial nephritis. Nephrol Dial Transplant 2013 ; 28 : 112-115.
PubMed
3. Wanchoo R, et al. Adverse renal effects of immune checkpoint inhibitors : A narrative review. Am J Nephrol 2017 ; 45 : 160-169.
PubMed
4. Muriithi AK, et al. Biopsy-proven acute interstitial nephritis, 1993-2011 : a case series. Am J Kidney Dis 2014 ; 64 : 558-566.
PubMed
5. Rossert J. Drug-induced acute interstitial nephritis. Kidney Int 2001 ; 60 : 804-817.
PubMed
6. Dixit MP, et al. Non-steroidal anti-inflammatory drugs-associated acute interstitial nephritis with granular tubular basement membrane deposits. Pediatr Nephrol 2008 ; 23 : 145-148.
PubMed
7. Ortiz A, et al. Ciprofloxacin-associated tubulointerstitial nephritis with linear tubular basement membrane deposits. Nephron 1992 ; 60 : 248.
PubMed
8. Lin CY, et al. Sodium-valproate-induced interstitial nephritis. Nephron 1988 ; 48 : 43-46.
PubMed
9. Gonzalez E, et al. Early steroid treatment improves the recovery of renal function in patients with drug-induced acute interstitial nephritis. Kidney Int 2008 ; 73 : 940-946.
PubMed
10. Hawkins EP, et al. Acute tubulointerstitial nephritis in children : clinical, morphologic, and lectin studies. A report of the Southwest Pediatric Nephrology Study Group. Am J Kidney Dis 1989 ; 14 : 466-471.
 
11. Vanhille P, et al. Drug-induced granulomatous interstitial nephritis. Proc Eur Dial Transplant Assoc 1983 ; 20 : 646-649.
PubMed
12. Dobrin RS, et al. Acute eosinophilic interstitial nephritis and renal failure with bone marrow-lymph node granulomas and anterior uveitis. A new syndrome. Am J Med 1975 ; 59 : 325-333.
PubMed
13. Mandeville JT, et al. The tubulointerstitial nephritis and uveitis syndrome. Surv Ophthalmol 2001 ; 46 : 195-208.
PubMed
14. Legendre M, et al. Clinicopathologic characteristics, treatment, and outcomes of tubulointerstitial nephritis and uveitis syndrome in adults : A national retrospective strobe-compliant study. Medicine (Baltimore) 2016 ; 95 : e3964.
PubMed
15. Francois H, et al. Renal involvement in primary Sjogren syndrome. Nat Rev Nephrol 2016 ; 12 : 82-93.
PubMed
16. Maripuri S, et al. Renal involvement in primary Sjogren's syndrome : a clinicopathologic study. Clin J Am Soc Nephrol 2009 ; 4 : 1423-1431.
PubMed
17. Goules AV, et al. Clinically significant renal involvement in primary Sjogren's syndrome : clinical presentation and outcome. Arthritis Rheum 2013 ; 65 : 2945-2953.
PubMed
18. Moutsopoulos HM, et al. Nephrocalcinosis in Sjogren's syndrome : a late sequela of renal tubular acidosis. J Intern Med 1991 ; 230 : 187-191.
PubMed
P.300 掲載の参考文献
1. Shah S, et al. Granulomatous interstitial nephritis. Clin Kidney J 2015 ; 8 : 516-523.
PubMed
2. Bijol V, et al. Granulomatous interstitial nephritis : a clinicopathologic study of 46 cases from a single institution. Int J Surg Pathol 2006 ; 14 : 57-63.
PubMed
3. Javaud N, et al. Renal granulomatoses : a retrospective study of 40 cases and review of the literature. Medicine 2007 ; 86 : 170-180.
PubMed
4. Hotta K, et al. Granulomatous tubulointerstitial nephritis in a renal allograft : three cases report and review of literature. Clin Transplant 2012 ; 26 (Suppl 24) : 70-75.
 
5. Mahevas M, et al. Renal sarcoidosis : clinical, laboratory, and histologic presentation and outcome in 47 patients. Medicine 2009 ; 88 : 98-106.
PubMed
6. Berliner AR, et al. Sarcoidosis : the nephrologist's perspective. Am J Kidney Dis 2006 ; 48 : 856-870.
PubMed
7. Joss N, et al. Granulomatous interstitial nephritis. Clin J Am Soc Nephrol 2007 ; 2 : 222-230.
PubMed
8. Maroz N, et al. Necrotizing crescentic glomerulonephritis related to sarcoidosis : a case report. J Med Case Rep 2015 ; 9 : 282.
PubMed
9. Stehle T, et al. Clinicopathological study of glomerular diseases associated with sarcoidosis : a multicenter study. Orphanet J Rare Dis 2013 ; 8 : 65.
PubMed
P.304 掲載の参考文献
1. Ronald A. The etiology of urinary tract infection : traditional and emerging pathogens. Dis Mon 2003 ; 49 : 71-82.
PubMed
2. Kimmelstiel P, et al. Inflammatory lesions in the glomeruli in pyelonephritis in relation to hypertension and renal insufficiency. Am J Pathol 1936 ; 12 : 99.
PubMed
3. Li L, et al. Xanthogranulomatous pyelonephritis. Arch Pathol Lab Med 2011 ; 135 : 671-674.
PubMed
4. Dobyan DC, et al. Renal malacoplakia reappraised. Am J Kidney Dis 1993 ; 22 : 243-252.
PubMed
P.310 掲載の参考文献
1. Hamano H, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 2001 ; 344 : 732-738.
PubMed
2. Hamano H, et al. Hydronephrosis associated with retroperitoneal fibrosis and sclerosing pancreatitis. Lancet 2002 ; 359 : 1403-1404.
PubMed
3. Kamisawa T, et al. A new clinicopathological entity of IgG4-related autoimmune disease. J Gastroenterol 2003 ; 38 : 982-984.
PubMed
4. Yamamoto M, et al. A new conceptualization for Mikulicz's disease as an IgG4-related plasmacytic disease. Mod Rheumatol 2006 ; 16 : 335-340.
 
5. Takeda S, et al. IgG4-associated idiopathic tubulointerstitial nephritis complicating autoimmune pancreatitis. Nephrol Dial Transplant 2004 ; 19 : 474-476.
 
6. 日本腎臓学会IgG4関連腎臓病ワーキンググループ : IgG4関連腎臓病診療指針. 日腎会誌 2011 ; 53 : 1062-1073.
 
7. Kawano M, et al. Proposal for diagnostic criteria for IgG4-related kidney disease. Clin Exp Nephrol 2011 ; 15 : 615-626.
PubMed
8. Stone JH, et al. IgG4-related disease. New Engl J Med 2012 ; 366 : 539-551.
PubMed
9. Saeki T, et al. IgG4-related kidney disease. Kidney Int 2014 ; 85 : 251-257.
PubMed
10. 久野敏. IgG4関連腎臓病と鑑別すべき間質性腎炎. 病理と臨床 2016 ; 34 : 1313-1316.
Medical*Online
11. Nakashima H, et al. An amplification of IL-10 and TGF-β in patients with IgG4-related tubulointerstitial nephritis. Clin Nephrol 2010 ; 73 : 385-391.
 
12. Kawamura E, et al. Immunohistological analysis for immunological response and mechanism of interstitial fibrosis in IgG4-related kidney disease. Mod Rheumatol 2015 ; 25 : 571-578.
PubMed
13. Hara S, et al. Distribution and components of interstitial inflammation and fibrosis in IgG4-related kidney disease : analysis of autopsy specimens. Human Pathol 2016 ; 55 : 164-173.
PubMed
14. 佐伯敬子. 臨床病態, 斉藤喬雄, ほか (編). IgG4関連腎臓病のすべて. 34-38, 東京 : 南江堂, 2014.
 
15. Hisano S. IgG4-related kidney disease : pathological features : other glomerular disease, In : Saito T, et al (ed), IgG4-Related Kidney Disease. 139-143, Tokyo : Springer, 2016.
 
16. Yamaguchi Y, et al. Characteristic tubulointerstitial nephritis in IgG4 related disease. Hum Pathol 2012 ; 43 : 536-549.
PubMed
17. 久野敏. 病理組織, 免疫組織的所見, 斉藤喬雄, ほか (編), IgG4関連腎臓病のすべて, 83-86, 東京 : 南江堂, 2014.
 
18. 山中宣昭. 病理組織, 電子顕微鏡所見, 斉藤喬雄, ほか (編), IgG4関連腎臓病のすべて, 87-94, 東京 : 南江堂, 2014.
 
P.320 掲載の参考文献
1. Finn LS. Renal disease caused by inborn errors of metabolism storage diseases, and hemoglobinopathies. Heptinstall's Pathology of the Kidney. volume II, 7th edition. 1223-1279, Philadelphia : Lippincott Williams & Wilkins, 2013.
 
2. Hall JE. Renal tubular reabsorption and secretion. In : Guyton and Hall Textbook of Medical Physiology. 13th edition, 347-369, Saunders/Elsevier : Philadelphia, 2015.
 
3. Tojo A. The role of the kidney in protein metabolism : the capacity of tubular lysosomal proteolysis in nephrotic syndrome. Kidney Int 2013 ; 84 : 861-863.
 
4. Vervaet BA, et al. An active crystal clearance mechanism in rat and man. Kidney Int 2009 ; 75 : 41-51.
PubMed
5. 山口聡, ほか. 尿酸代謝と尿路結石症. 痛風と核酸代謝 2002 ; 26 : 1-11.
 
6. Tojo A, et al. The reduced expression of proximal tubular transporters in acquired Fanconi syndrome withκlight chain deposition. Med Mol Morphol 2016 ; 49 : 48-52.
 
7. Onozato ML, et al. Tubulointerstitial nephritis associated with acute intermittent porphyria. Clin Nephrol 2001 ; 55 : 171-174.
PubMed
8. Seyberth HW, et al. Bartter- and Gitelman-like syndromes : salt-losing tubulopathies with loop or DCT defects. Pediatr Nephrol 2011 ; 26 : 1789-1802.
 
9. Tojo A, et al. Localization and mechanism of nephrocalcinosis in pseudo-Bartter's syndrome. Kidney Int 2010 ; 77 : 831.
PubMed
P.325 掲載の参考文献
1. Hildebrandt F, et al. Nephronophthisis : disease mechanisms of a ciliopathy. J Am Soc Nephrol 2009 ; 20 : 23-35.
PubMed
2. Hamiwka LA, et al. Outcomes of kidney transplantation in children with nephronophthisis : an analysis of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) Registry. Pediatr Transplant 2008 ; 12 : 878-882.
PubMed
3. Bleyer AJ, et al. Autosomal dominant tubulointerstitial kidney disease : diagnosis, classification, and management-A KDIGO consensus report. Kidney Int 2015 ; 88 : 676-683.
PubMed
4. Ekici AB, et al. Renal fibrosis is the common feature of autosomal dominant tubulointerstitial kidney diseases caused by mutations in mucin 1 or uromodulin. Kidney Int 2014 ; 86 : 589-599.
PubMed
5. Zollinger HU, et al. Nephronophthisis (medullary cystic disease of the kidbney). A study using electron microscopy, immunofluorescence, and a review of the morphologiucal findings. Helv Pediatr Acta 1980 ; 35 : 509-530.
 
6. Yamamoto S, et al. Analysis of an ADTKD family with a novel frameshift mutation in MUC1 reveals characteristic features of mutant MUC1 protein. Nephrol Dial Transplant gfx083 2017. DOI : https://doi.org/10.1093/ndt/gfx083
 

各論 : 移植腎病変

P.336 掲載の参考文献
1. Loupy A, et al. The Banff 2015 Kidney meeting report : Current challenges in rejection classification and prospects for adopting molecular pathology. Am J Transplant 2017 ; 17 : 28-41.
PubMed
2. Kanetsuna Y, et al. C4d and/or immunoglobulins deposition in peritubular capillaries in perioperative graft biopsies in ABO-incompatible renal transplantation. Clin Transplant 2004 ; 18 (Suppl 11) : 13-17.
PubMed
3. Aita K, et al. Thickening of the peritubular capillary basement membrane is a useful diagnostic marker of chronic rejection in renal allografts. Am J Transplant 2007 ; 7 : 923-929.
PubMed
4. Yi-Chun XD, et al. Markers of Endothelial-to-Mesenchymal Transition : Evidence for Antibody-Endothelium Interaction during Antibody-Mediated Rejection in Kidney Recipients. J Am Soc Nephrol 2016 ; 27 : 324-332.
 
5. Sis B, et al. Isolated endarteritis and kidney transplant survival : a multicenter collaborative study. J Am Soc Nephrol 2015 ; 26 : 1216-1227.
PubMed
6. Mannon RB, et al. Inflammation in areas of tubular atrophy in kidney allograft biopsies : a potential predictor of allograft failure. Am J Transplant 2010 ; 10 : 2066-2073.
 
7. Solez K, et al. Banff 07 classification of renal allograft pathology : updates and future directions. Am J Transplant 2008 ; 8 : 753-760.
PubMed
8. Haas M, et al. Banff 2013 meeting report : inclusion of C4d-negative antibody-mediated rejection and antibody-associated arterial lesions. Am J Transplant 2014 ; 14 : 272-283.
PubMed
9. Loupy A, et al. Outcome of subclinical antibody-mediated rejection in kidney transplant recipients with preformed donor-specific antibodies. Am J Transplant 2009 ; 9 : 2561-2570.
PubMed
10. Stegall M, et al. The role of complement in antibody-mediated rejection in kidney transplantation. Nat Rev Nephrol 2012 ; 8 : 670-678.
PubMed
11. Elshafie M, et al. Identification of lesions indicating rejection in kidney transplant biopsies : tubulitis is severely under-scored by conventional microscopy. Nephrol Dial Transplant 2012 ; 27 : 1252-1255.
 
12. Nadasdy T. Thrombotic microangiopathy in renal allografts : the diagnostic challenge. Transplantation 2014 ; 19 : 283-292.
 
13. Liapis G, et al. Diagnostic significance of peritubular capillary basement membrane multilaminations in kidney allografts : old concepts revisited. Transplantation 2012 ; 94 : 620-629.
PubMed
14. Sellares J, et al. Molecular diagnosis of antibody-mediated rejection in human kidney transplants. Am J Transplant 2013 ; 13 : 971-983.
PubMed
15. Reeve J, et al. Molecular diagnosis of T cell-mediated rejection in human kidney transplant biopsies. Am J Transplant 2013 ; 13 : 645-655.
PubMed
P.341 掲載の参考文献
1. Burdmann EA, et al. Cyclosporine nephrotoxicity. Semin Nephrol 2003 ; 23 : 465-476.
PubMed
2. Naesens M, et al. Calcineurin inhibitor nephrotoxicity. Clin J Am Soc Nephrol 2009 ; 4 : 481-508.
PubMed
3. Kobayashi A, et al. Medullary ray injury in renal allografts. Pathol Int 2010 ; 60 : 744-749.
PubMed
4. Mihatsch MJ, et al. Renal transplant morphology after long-term therapy with cyclosporine. Transplant Proc 1995 ; 27 : 39-42.
PubMed
5. Snanoudj R, et al. Specificity of histopathological markers of long-term CNI nephrotoxicity in kidney-transplant recipients under low-dose cyclosporine therapy. Am J Transplant 2011 ; 11 : 2635-2646.
 
P.349 掲載の参考文献
1. De Gascun CF, et al. Human polyomavirus reactivation : disease pathogenesis and treatment approaches. Clin Dev Immunol 2013 ; 2013. Article ID 373579
 
2. Nickeleit V, et al. Polyomaviruses and disease : is there more to know than viremia and viruria? Curr Opin Organ Transplant 2015 ; 20 : 348-358.
PubMed
3. Sharif A, et al. Incidence and outcomes of BK virus allograft nephropathy among ABO- and HLA-Incompatible kidney transplant recipients. Clin J Am Soc Nephrol 2012 ; 7 : 1320-1327.
PubMed
4. Hirsch HH, et al. AST Infectious Diseases Community of Practice. BK Virus in Solid Organ Transplant Recipients. Am J Transplant 2009 ; 9 (Suppl 4) : S136-S146.
 
5. 武田朝美, ほか. 腎移植とウイノレス感染. 日腎会誌 2004 : 46 : 661-666.
 
6. Nickleit V, et al. Renal Transplant pathology, infections. Jennette JC, et al (ed). Heptinstall's Pathology of the Kidney. 7th edition. 1403-1413, Philadelphia : Lippincott Williams & Wilkins, 2015.
 
7. Menter T, et al. Pathology of Resolving Polyomavirus-Associated Nephropathy. Am J Transplant 2013 ; 13 : 1474-1483.
PubMed
8. Sar A, et al. Interobserver agreement for polyomavirus nephropathy grading in renal allografts using the working proposal from the 10th Banff Conference on Allograft Pathology. Hum Pathol 2011 ; 42 : 2018-2024.
PubMed
9. Ramos E, et al. The Decade of Polyomavirus BK-Associated Nephropathy : State of Affairs. Transplantation 2009 ; 87 : 621-630.
PubMed
10. Haas M, et al. Banff 2013 Meeting Report : Inclusion of C4d-Negative Antibody-Mediated Rejection and Antibody-Associated Arterial Lesions. Am J Transplant 2014 ; 14 : 272-283.
PubMed
11. 原重雄. バンフミーティング2015報告 (移植腎病理). 病理と臨床 2016 ; 34 : 185-189.
Medical*Online
12. Storsley L, et al. Adenovirus interstitial nephritis and rejection in an allograft. J Am Soc Nephrol 2011 ; 22 : 1423-1427.
 
13. Singh HK, et al. Kidney disease caused by viral infections. Curr Diag Pathol 2004 ; 10 : 11-21.
 
14. Rady K, et al. Allograft adenovirus nephritis. Clin Kidney J 2014 ; 7 : 289-292.
PubMed
15. Onuigbo M, et al. Cytomegalovirus induced glomerular vasculopathy in renal allografts : a report of two cases. Am J Transplant 2002 ; 2 : 684-688.
PubMed
16. 京昌弘, ほか. 移植腎のウイルス感染症. 両角園男, ほか (編). 移植腎臨床病理アトラス カルシニューリンインヒビターと腎. 263-275, 東京 : 東京医学社, 2005.
 
P.354 掲載の参考文献
1. Swerdlow SH, et al. Post-transplant lymphoproliferative disorders. In : WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues 4th Edition, 343-349, Lyon : International Agency for Research on Cancer, 2008.
 
2. Brunstein CG, et al. Marked increased risk of Epstein-Barr virusrelated complications with the addition of antithymocyte globulin to a non-myeloablative conditioning prior to unrelated umbilical cord blood transplantation. Blood 2006 ; 108 : 2874-2880.
 
3. Dotti G, et al. Primary effusion lymphoma after heart transplantation : a new entity associated with human herpes virus-8. Leukemia 1999 ; 13 : 664-670.
PubMed
4. Bakker MH, et al. Early onset post-transplant lymphoproliferative disease is associated with allograft localization. Clin Transplant 1995 ; 19 : 327-334.
 
5. Swerdlow SH, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 2016 ; 127 : 2375-2390.
PubMed
6. Dierickx D, et al. How I treat posttransplant lymphoproliferative disorders. Blood 2015 ; 126 : 2274-2283.
 
P.360 掲載の参考文献
1. Morozumi K, et al. Recurrent glomerular disease after kidney transplantation : an update of selected areas and the impact of protocol biopsy. Nephrology 2014 ; 19 (Suppl 3) : 6-10.
 
2. 日本移植学会, 日本臨床腎移植学会. 腎移植臨床登録集計報告 (2016) 2015年実施症例の集計報告と追跡調査結果. 移植 2016 ; 51 : 124-144.
Medical*Online
3. Moroni G, et al. The long-term outcome of renal transplantation of IgA nephropathy and the impact of recurrence on graft survival. Nephrol Dial Transplant 2013 ; 28 : 1305-1314.
 
4. Dabade TS, et al. Recurrent idiopathic membranous nephropathy after kidney transplantation : a surveillance biopsy study. Am J Transplant 2008 ; 8 : 1318-1322.
PubMed
5. Zand L, et al. Clinical findings, pathology, and outcomes of C3GN after kidney transplantation. J Am Soc Nephrol 2014 ; 25 : 1110-1117.
PubMed
6. Nasr SH, et al. Proliferative glomerulonephritis with monoclonal IgG deposits recurs in the allograft. Clin J Am Soc Nephrol 2011 ; 6 : 122-132.
PubMed
7. Choy BY, et al. Recurrent glomerulonephritis after kidney transplantation. Am J Transplant 2006 ; 6 : 2535-2542.
PubMed
8. Honda K, et al. De novo membranous nephropathy and antibodymediated rejection in transplanted kidney. Clin Transplant 2011 ; 25 : 191-200.
PubMed

各論 : 随伴性腎疾患

P.366 掲載の参考文献
1. Hingorani S. Renal complications of hematopoietic-cell transplantation. N Engl J Med 2016 ; 374 : 2256-2267.
PubMed
2. Troxell ML, et al. Renal pathology associated with hematopoietic stem cell transplantation. Adv Anat Pathol 2014 ; 21 : 330-340.
PubMed
3. Singh N, et al. Kidney complications of hematopoietic stem cell transplanatation. Am J Kidney Dis 2013 ; 61 : 809-821.
 
4. Brinkerhoff BT, et al. Renal pathology in hematopoietic cell transplant recipients : a contemporary biopsy, nephrectomy, and autopsy series. Mod Pathol 2016 ; 29 : 637-652.
PubMed
5. Ho VT, et al. Blood and marrow transplant clinical trials network toxicity committee consensus summary : Thrombotic microangiopathy after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2005 ; 11 : 571-575.
PubMed
6. Mii A, et al. Renal thrombotic microangiopathy associated with chronic graft-versus-host disease after allogenic hematopoietic stem cell transplantation. Pathol Int 2011 ; 61 : 518-527.
PubMed
7. Beyar-Katz O, et al. Adult nephrotic syndrome after hematopoietic stem cell transplantation : Renal pathology is the best predictor of response to therapy. Biol Blood Marrow Transplant 2016 ; 22 : 975-981.
PubMed
8. Hiramatsu R, et al. Clinicopathological analysis of allogneic hematopoietic stem cell transplantation-related membranous glomerulonephritis. Hum Pathol 2016 ; 50 : 187-194.
 
9. Otani M, et al. Renal involvement in bone marrow transplantation. Nephrology (Carlton) 2005 ; 10 : 530-536.
PubMed
10. 藤井晶子, ほか. 骨髄移植 (造血幹細胞移植) に伴う腎病変. 病理と臨床 2016 ; 34 : 1331-1336.
Medical*Online
P.369 掲載の参考文献
1. 日本妊娠高血圧学会 (編). 妊娠高血圧症候群の診療指針 2015, 第4版, 東京 : メジカルレビュー社.
 
2. Fogo AB. Renal disease in pregnancy. Jennette JC et al. Heptinstall's Pathology of The Kidney. Vol 2, 7th ed. 815-847, Philadelphia : Wolters Kluwer, 2015.
 
3. Hladunewich M, et al. Pathophysiology of the clinical manifestation of preeclampsia, Clin J Am Soc Nephrol 2007 ; 2 : 543-549.
PubMed
4. Young BC, et al. Pathogenesis of preeclampsia. Annu Rev Pathol Mech Dis 2010 ; 5 : 173-192.
 
5. Chaiworapongsa T, et al. Pre-eclampsia part 1 : current understanding of its pathophysiology. Nat Rev Nephrol 2014 ; 10 : 466-480.
PubMed
6. Stillman IE, et al. The glomerular injury of preeclampsia. J Am Soc Nephrol 2007 ; 18 : 2281-2284.
PubMed
7. Krane NK. Acute renal failure in pregnancy. Arch Intern Med 1988 ; 148 : 2347-2357.
PubMed
P.373 掲載の参考文献
1. Izzedine H, et al. Kidney diseases associated with anti-vascular endothelial growth factor (VEGF). Medicine 2014 ; 93 : 333-339.
PubMed
2. Eremina V, et al. VEGF inhibition and renal thrombotic mictoangiopathy. N Engl J Med 2008 ; 358 : 1129-1136.
PubMed
3. Noronha V, et al. Sunitinib-induced thrombotic microangiopathy. J Can Res Ther 2016 ; 12 : 6-11.
PubMed
4. Launay-Vacher V, et al. Renal effects of molecular targeted therapies in oncology : a review by the cancer and kidney international network (C-KIN). Ann Oncolo 2015 ; 26 : 1677-1684.
 
5. Sartelet H, et al. Sirolimus-induced thrombotic microangiopathy is associated with decreased expression of vascular endothelial growth factor in kidneys. Am J Transplant 2005 ; 5 : 2441-2447.
PubMed
6. El Rassy E, et al. Onconephrology : What should internist know about targeted therapy in solid tumors? Iran J Kidney Dis 2016 ; 10 : 169-175.
PubMed
7. Kelly RJ, et al. Renal toxicity of targeted therapies. Targ Oncol 2009 : 4 : 121-133.
 
8. Shirali AC, et al. Association of acute interstitial nephritis with programmed cell death 1 inhibitor therapy in lung cancer patients. Am J Kidney Dis 2016 ; 68 : 287-291.
PubMed
P.378 掲載の参考文献
1. 小島勝. 非腫瘍性リンパ増殖性疾患. 診断病理 2013 ; 30 : 173-184.
Medical*Online
2. Castleman B, et al. Localized mediastinal lymphnode hyperplasia resembling thymoma. Cancer 1956 ; 9 : 822-830.
PubMed
3. Peterson BA, et al. Multicentric Castleman's disease. Semin Oncol 1993 ; 20 : 636-647.
PubMed
4. Sato Y, et al. Sytemic IgG4-related lymphadenopathy : a clinical and pathologic comparison to multicentric Castleman's disease. Mod Pathol 2009 ; 22 : 589-599.
 
5. 高井和江, ほか. 発熱, 胸腹水, 肝脾腫を伴い, 骨髄に軽度の線維化を認める血小板減少症. 臨床血液 2010 ; 51 : 320-325.
 
6. Yuan XG, et al. Renal complications of Castleman's disease : report of two cases and analysis of 75 cases. Clin Exp Nephrol 2011 ; 15 : 921-926.
PubMed
7. Nakamoto Y, et al. A spectrum of clinicopathological features of nephropathy associated with POEMS syndrome. Nephrol Dial Transplant 1999 ; 14 : 2370-2378.
PubMed
8. 正木康史, ほか. 新規疾患TAFRO症候群の診断基準・重症度分類・治療指針. 臨床血液 2016 ; 57 : 2029-2037.
 
9. Kurosawa S, et al. Idiopathic plasmacytic lymphadenopathy with polyclonal hypergammaglobulinemia accompanied with cutaneous involvement and renal dysfunction. Jpn J Clin Oncol 2009 ; 39 : 682-685.
PubMed
10. 冨田茂樹, ほか. M蛋白関連腎症の最新の進歩. 病理と臨床 2016 ; 34 : 1296-1303.
Medical*Online

書評

最近チェックした商品履歴

Loading...